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Abstract
Chronic alcohol consumption causes health problems including cancers, liver damage, and
cirrhosis.These problems are exacerbated by endotoxins from the bacterial population of the colon, which
can enter the bloodstream when gastrointestinal tight junctions, protein complexes that prevent
paracellular passage of molecules, are compromised. The mechanisms of this barrier disruption are the
subject of current study.
Acetaldehyde, produced as a result of ethanol breakdown by intestinal microflora as well as intestinal
epithelia, is a known carcinogen. It compromises the barrier function of intestinal epithelial cells by
causing irregularities in the phosphorylation of tight junction proteins. It also reacts with proteins, lipids,
and DNA to cause cellular malfunction.
This project explored the roles of PP2A (a protein phosphatase) in acetaldehyde-mediated tight junction
disruption, wound healing, and morphological differentiation. Intestinal epithelial cell culture in
monolayers on permeable membranes were used to test the effects of acetaldehyde in the presence or
absence of specific inhibitors on barrier function via transepithelial resistance and the paracellular
passage of fluorescent molecules. Immunocytochemistry and confocal microscopy were used to track
the localization of occludin in the cell lines tested, in cells cultured in monolayers or in a threedimensional model in Matrigel. Results for acute administration of acetaldehyde were confirmed in
mouse ileum.
Acute administration of acetaldehyde was demonstrated to have deleterious effects on the barrier
function and wound healing of Caco-2 cells and mouse ileum, with varying degrees of attenuation of the
effects of acetaldehyde via PP2A inhibition. Transepithelial resistance declined and inulin flux increased
in the presence of acetaldehyde, as occludin was dephosphorylated and internalized by the cell in the
presence of increased PP2A association and activity. PP2A inhibition by fostriecin, siRNA, or a specific
peptide inhibitor not only rescued the cells from the disruption indicated by inulin flux, but also decreased
the association of PP2A with occludin, resulting in preservation of threonine phosphorylation and
localization of occludin at the tight junction. These results were confirmed by experiments with fostriecin
in mouse ileum ex vivo. At all concentrations tested, acute exposure to acetaldehyde inhibited wound
healing in an established in vitro model. Migration was not restored by PP2A inhibition, indicating that
acetaldehyde's effects on wound healing were PP2A independent.
Chronic exposure to acetaldehyde disrupted differentiation in cells grown in Matrigel, as shown by
changes in morphology, in a manner attenuated by fostriecin pretreatment. These results indicated that
the known effects of acetaldehyde on cell differentiation may be PP2Adependent, and that intact tight
junctions with appropriately-phosphorylated proteins may be important for maintaining the polarity of
differentiated Caco-2 cells.
In conclusion, acetaldehyde disrupted tight junction barrier via occludin dephosphorylation by PP2A to
cause leaky epithelia and deficient differentiation of cells. It slowed wound healing in a PP2A-independent
manner. All of these findings contribute to an understanding of the mechanisms by which acetaldehyde
causes health problems in alcoholics
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ABSTRACT
Chronic alcohol consumption causes health problems including cancers, liver
damage, and cirrhosis.These problems are exacerbated by endotoxins from the bacterial
population of the colon, which can enter the bloodstream when gastrointestinal tight
junctions, protein complexes that prevent paracellular passage of molecules, are
compromised. The mechanisms of this barrier disruption are the subject of current study.
Acetaldehyde, produced as a result of ethanol breakdown by intestinal microflora
as well as intestinal epithelia, is a known carcinogen. It compromises the barrier function
of intestinal epithelial cells by causing irregularities in the phosphorylation of tight
junction proteins. It also reacts with proteins, lipids, and DNA to cause cellular
malfunction.
This project explored the roles of PP2A (a protein phosphatase) in acetaldehydemediated tight junction disruption, wound healing, and morphological differentiation.
Intestinal epithelial cell culture in monolayers on permeable membranes were used to test
the effects of acetaldehyde in the presence or absence of specific inhibitors on barrier
function via transepithelial resistance and the paracellular passage of fluorescent
molecules. Immunocytochemistry and confocal microscopy were used to track the
localization of occludin in the cell lines tested, in cells cultured in monolayers or in a
three-dimensional model in Matrigel. Results for acute administration of acetaldehyde
were confirmed in mouse ileum.
Acute administration of acetaldehyde was demonstrated to have deleterious
effects on the barrier function and wound healing of Caco-2 cells and mouse ileum, with
varying degrees of attenuation of the effects of acetaldehyde via PP2A inhibition.
Transepithelial resistance declined and inulin flux increased in the presence of
acetaldehyde, as occludin was dephosphorylated and internalized by the cell in the
presence of increased PP2A association and activity. PP2A inhibition by fostriecin,
siRNA, or a specific peptide inhibitor not only rescued the cells from the disruption
indicated by inulin flux, but also decreased the association of PP2A with occludin,
resulting in preservation of threonine phosphorylation and localization of occludin at the
tight junction. These results were confirmed by experiments with fostriecin in mouse
ileum ex vivo. At all concentrations tested, acute exposure to acetaldehyde inhibited
wound healing in an established in vitro model. Migration was not restored by PP2A
inhibition, indicating that acetaldehyde's effects on wound healing were PP2A
independent.
Chronic exposure to acetaldehyde disrupted differentiation in cells grown in
Matrigel, as shown by changes in morphology, in a manner attenuated by fostriecin
pretreatment. These results indicated that the known effects of acetaldehyde on cell
differentiation may be PP2A-dependent, and that intact tight junctions with
appropriately-phosphorylated proteins may be important for maintaining the polarity of
differentiated Caco-2 cells.
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In conclusion, acetaldehyde disrupted tight junction barrier via occludin
dephosphorylation by PP2A to cause leaky epithelia and deficient differentiation of cells.
It slowed wound healing in a PP2A-independent manner. All of these findings contribute
to an understanding of the mechanisms by which acetaldehyde causes health problems in
alcoholics.
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CHAPTER 1.

INTRODUCTION

Ethanol Breakdown, Enzymes, and Products
Ethanol consumption has been linked to a variety of health problems ranging from
neurodegeneration to liver disease to aerodigestive and other cancers. It is estimated to be
linked to approximately 4% of deaths and 5% of years lost to disability worldwide (IARC
2010). Studies in Mumbai, India have found increased risk of death from liver disease,
digestive disease, tuberculosis, oral cancer, and cardiovascular disease among drinkers
consuming more than 33 g ethanol per day (Pednekar, Sansone, and Gupta 2011). Studies
in Italian alcoholics have found a several-fold increased risk of death from liver cirrhosis,
respiratory diseases, mental illness, diabetes, cardiovascular disease, cancer, and
infectious disease (Saieva et al. 2012). Many of these health problems can be linked
directly to the enzymatic breakdown of ethanol to form acetaldehyde, then acetate.
Acetate is innocuous, but acetaldehyde can bind to a variety of proteins, lipids, and DNA
in the cell, forming adducts. These adducts can interfere with normal cellular enzymatic
reactions, slowing reaction rates and forming abnormal by-products. Acetaldehyde
disrupts intracellular junctions in different epithelia to allow foreign substances into the
body, causing further havoc. Ethanol breakdown in general and acetaldehyde processing
in particular cause destructive consequences in the cells of persons engaging in acute or
chronic high levels of alcohol consumption.
Ethanol breakdown occurs in one major pathway and several minor ones,
which can be classified as oxidative and non-oxidative. The major pathway is conversion
by alcohol dehydrogenase (ADH) to form acetaldehyde, with further breakdown by
aldehyde dehydrogenase (ALDH) to form acetate. Each dehydrogenation causes
reduction of NAD to NADH, which can cause changes in the redox status of cells with
continued ethanol exposure (Lieber 2005) (Figure 1-1).
Other oxidative processes also exist. Cytochrome P4502E1 (CYP2E1) and
catalase are activated by high levels of ethanol, resulting in added production of
acetaldehyde. CYP2E1 produces hydroxyethyl radicals as well as acetaldehyde, adding to
the oxidative stress of the cell (Comporti et al. 2010). These species add to the cellular
stress by their production of acetaldehyde and other molecules.
Non-oxidative ethanol processing occurs through fatty-acid-processing
enzymes and phospholipase D (PLD) . Ethanol competes with phosphatidylcholine, the
normal substrate of PLD. Instead of phosphatidic acid, an important second messenger in
proliferative pathways, PLD produces phosphatidylethanol by the process of
transphosphatidylation (Rydzewska, Jurkowska, and Gabryelewicz 1996).Fatty acid
processing enzymes such as fatty acid ethyl ester synthase form compounds such as ethyl
stearate and ethyl palmitate (Pragst et al. 2001; Best and Laposata 2003), which stimulate
toxic calcium release in sensitive cells (Petersen et al. 2009). These non-oxidative forms
of ethanol processing can be lethal to cells in the pancreas and toxic in other tissues
(Figure 1-2).
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Figure 1-1. Reactions Forming Acetaldehyde in Humans
These reactions oxidize ethanol to form acetaldehyde. CH3-CH2OH is ethanol. CH3CHO
is acetaldehyde. NADH is nicotinamide adenine dinucleotide (reduced from NAD).
NADPH is nicotinamide adenine dinucleotide phosphate (reduced from NADP+).
Source: Reprinted with permission. Comporti M, C Signorini, S Leoncini, C Gardi, L
Ciccoli, A Giardini, D Vecchio, and B Arezzini. 2010. “Ethanol-induced Oxidative
Stress: Basic Knowledge.” Genes & Nutrition 5 (2) (June): 101–109.
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Figure 1-2. Fatty Acid Ethyl Ester Formation and Breakdown
A summary of reactions forming and breaking down fatty acid ethyl esters indicates a
variety of lipid pools contributing to FAEE formation.
Source: Reprinted with permission. Pragst F, V Auwaerter, F Sporkert, and K Spiegel.
2001. “Analysis of Fatty Acid Ethyl Esters in Hair as Possible Markers of Chronically
Elevated Alcohol Consumption by Headspace Solid-phase Microextraction (HS-SPME)
and Gas Chromatography-mass Spectrometry (GC-MS).” Forensic Science International
121 (1–2) (September 15): 76–88.
ADH, NADH, ALDH2
When humans consume ethanol, acetaldehyde is produced by ADH in epithelial
tissues lining the digestive tract and by bacteria and yeast occupying various parts of the
digestive tract. The acetaldehyde is further broken down to acetate by ALDH, an enzyme
with low activity in intestinal bacteria, but higher activity in human epithelial cells
(Salaspuro 1996).
Mutations in the genes for these enzymes cause alterations in function, resulting
in faster or slower processing of acetaldehyde by intestinal epithelial cells (Seitz and
Becker 2007). For example, the His47Arg mutation in ADH1B results in higher risk of
colorectal cancer (Gao et al. 2008). This mutation attenuates the activity of ADH1B, an
isoform of ADH found in the liver (CH Cho and Purohit 2006). The resulting increased
blood alcohol levels may increase the risk of colorectal cancer by unknown mechanisms,
or may provide more alcohol for the action of bacterial ADH in the gastrointestinal tract,
resulting in colonic acetaldehyde accumulation (Matsuo et al. 2006).
There are three different allelic variants of the ADH1B gene responsible for most
ethanol processing in the liver (Edenberg 2007). ADH1B*1, the reference allele common
in Caucasians, has an Arg at positions 48 and 370 (Table 1-1). ADH1B*2 has a histidine
at position 48. ADH1B*3 has a cysteine at position 370. Both of these mutations increase
the turnover rate of the enzyme 70 to 80 fold because nicotinamide adenine dinucleotide
(NADH) is released more quickly at the end of the reaction than usual (Edenberg 2007).
Fast ADH processing can result in buildup of acetaldehyde in the system, resulting in

3

Table 1-1. Important ADH and ALDH Polymorphisms
Class and Gene
ADH
I.

II.
III.
IV.
V.

Tissue Distribution

ADH1A
ADH1B*1
ADH1B*2
ADH1B*3
ADH2
ADH3
ADH4
ADH5

liver, lungs, kidneys
liver, lungs, kidneys
liver, lungs, kidneys
liver
all tissues
stomach, esophagus, liver, skin, cornea
stomach
all tissues

ALDH1
ALDH2*1
ALDH2*2

liver, stomach, brain (cytosol)
liver (mitochondrion)
liver, stomach (mitochondrion)

ALDH
I.
II.

Source: Reprinted with permission. Jelski W, and M Szmitkowski. 2008. “Alcohol
Dehydrogenase (ADH) and Aldehyde Dehydrogenase (ALDH) in the Cancer Diseases.”
Clinica Chimica Acta; International Journal of Clinical Chemistry 395 (1-2)
(September): 1–5. Copyright 2008 Elsevier.
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increased risk of acetaldehyde-specific, alcohol-related health problems (Jelski and
Szmitkowski 2008).
ALDH mutations can also cause problems. The ALDH2 Glu487Lys mutation
causes inactivation of ALDH, resulting in build-up of acetaldehyde in the system, facial
flushing, and other symptoms (Yin et al. 2007). These symptoms usually protect a person
from excessive alcohol consumption, but heterozygotes may tolerate the symptoms,
continue to drink heavily, and increase their risk of cancer (A. Yokoyama et al. 2008).
The ALDH2 Glu487Lys mutation is common in Asian populations (Eng, Luczak, and
Wall 2007).
These ADH and ALDH mutations contribute to malfunctions in the colon. Studies
from Japan and Taiwan have implicated the inactive ALDH2 and over-active ADH genes
common in Asians in an increased risk of colorectal cancer among Asian alcoholics (T.
Yokoyama et al. 2005; Chiang et al. 2012). In both cases, a build-up of acetaldehyde in
the colon is part of the mechanism of increased risk.
CYP450 2E1 (Mitochondrial Ethanol Oxidizing System)
CYP2E1 is induced by high levels of ethanol in cells, via chronic alcohol
consumption. CYP2E1 processes alcohol to acetaldehyde, but produces superoxide
radicals as unwanted byproducts, resulting in cellular damage (Lieber 2005)
(Figure 1-1). When CYP2E1 is activated, it also processes exogenous chemicals in the
body, such as carbon tetrachloride and bromobenzene, to toxic metabolites (Lieber 2005).
This accounts for excessive liver toxicity of acetaminophen in alcoholics, as the alcohol
and the acetaminophen act synergistically to activate CYP2E1 and harm the liver. Shortly
after ceasing excessive alcohol consumption, alcoholics are particularly vulnerable to the
toxic effects of CYP2E1 as the alcohol stops competing for the enzyme, and toxic
metabolites of other environmental chemicals reach their peak (Gonzalez 2005).
CYP2E1 activation has been shown to occur in the colonic mucosa of rats and
humans exposed to alcohol (Seitz, Maurer, and Stickel 2005), and may contribute to the
higher risk of colon cancer in alcoholics by several mechanisms. CYP2E1 generates
acetaldehyde, which is both mutagenic and carcinogenic (Salaspuro 2009). CYP2E1
induction by ethanol consumption is known to increase the effects of dietary nitrosamines
by generating DNA adducts (Gonzalez 2005). CYP2E1 may also play a role in colonic
hyper-regeneration in rats exposed to chronic alcohol consumption, as exposure to alpha
tocopherol, a radical scavenger, alleviates alcohol-induced colonic hyper-regeneration
(Vincon et al. 2003). Since colonic hyper-regeneration increases the risk of colon cancer
in humans, the activation of CYP2E1 in the presence of heavy alcohol consumption may
be part of the pathogenesis of alcohol-related colorectal cancer.
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Catalase
Catalase is an enzyme found in peroxisomes that is capable of oxidizing alcohol to
acetaldehyde in the presence of hydrogen peroxide (Keilin and Hartree 1945). It uses
hydrogen peroxide to oxidize alcohol to acetaldehyde, but "leaks" free radical species in
the process (Figure 1-1). Hydrogen peroxide generating enzymes such as xanthine
oxidase and NADPH oxidase are necessary for its function. It seems to be an important
source of ethanol oxidation in the kidney, heart, and brain (Orellana et al. 1998; Pastor,
Sanchis-Segura, and Aragon 2002; Zimatkin and Buben 2007), but relatively
insignificant in the liver (Lieber 2005).
FAEE Formation
Fatty acid ethyl esters (FAEEs) form as a minor product during the non-oxidative
elimination of ethanol (Figure 1-2). They accumulate in the pancreas, liver, and heart
during acute ethanol administration (Laposata and Lange, 1986), organs damaged in
many alcoholics. It has been shown in the pancreas that FAEEs cause lethal release of
calcium from the endoplasmic reticulum, resulting in calcium-dependent necrosis
(Petersen et al. 2009). The binding of FAEEs to mitochondrial membranes may
contribute to malfunction of oxidative phosphorylation and generation of toxic fatty acids
(Lange and Sobel 1983).
PLD
Phospholipase D is a membrane-associated enzyme that normally cleaves
phosphatidylcholine to release phosphatidic acid (Figure 1-3). It also produces the
important signaling molecules diacylglycerol and lysophosphatidic acid. These molecules
participate in signaling pathways such as regulation of kinases and matrix
metalloproteinases (Liscovitch et al. 2000). PLD is also essential for acetylcholine
formation in cholinergic neurons.
PLD can use short-chain alcohols as substrates to produce phosphatidylethanol
(Liscovitch et al. 2000). Phosphatidylethanol accumulation has been shown to increase
colonic cell proliferation and intestinal hyperplasia in rats (Pannequin et al. 2007). PLD
has also been shown to be inhibited by ethanol in the rat pancreas (Rydzewska,
Jurkowska, and Gabryelewicz 1996). Inhibition of PLD and competition as a substrate by
ethanol disrupt the signaling pathways (such as stimulation of PKCs and MAPKs)
normally modulated by the products of PLD.
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Figure 1-3. Effects of Ethanol on PLD Signaling
Ethanol competes with phosphatidylcholine for the activity of phospholipase D, resulting
in formation of non-functional phosphatidylethanol instead of phosphatidic acid (PA).
Source: Reprinted with permission. Liscovitch, M, M Czarny, G Fiucci, and X Tang.
2000. “Phospholipase D: Molecular and Cell Biology of a Novel Gene Family.”
Biochemical Journal 345: 401–415.
Acetaldehyde Pharmacology
General Description
Acetaldehyde, also known as ethanal or CH3CHO, is one of the "aromatics",
volatile compounds found in low concentration in alcoholic beverages which give them a
characteristic bouquet (Regodon Mateos, Perez-Nevado, and Ramirez Fernandez 2006).
At low concentrations it contributes to a fruity aroma in alcoholic beverages, but in high
concentrations it is pungent and unpleasant. It is produced by the yeast during
fermentation from pyruvate, by the enzyme pyruvate decarboxylase (Lees and Jago
1978). The different yeast strains used to ferment alcoholic beverages produce different
amounts of acetaldehyde (Querol et al. 2003) under different growth conditions (Roustan
and Sablayrolles 2002; Regodon Mateos, Perez-Nevado, and Ramirez Fernandez 2006).
Home-brewed and distilled alcoholic beverages tend to have higher acetaldehyde levels
than those produced in large-scale facilities (Boffetta et al. 2011), as temperature and
brewing conditions change microflora and the resulting acetaldehyde content.
Human ingestion of ethanol results in acetaldehyde production, as ethanol is
broken down to acetaldehyde by gastrointestinal microflora and epithelial cells. About
2-10% of ethanol taken orally can be eliminated through the kidneys or lungs (Lieber
2005). The rest is metabolized by the body, mostly in the liver, resulting in low blood
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acetaldehyde levels under normal conditions (Lieber 2005) Acetaldehyde production can
be measured in saliva following ethanol ingestion, both from acetaldehyde in the
beverage and endogenous production by oral microflora, with heavy smokers and
drinkers having higher levels of acetaldehyde production (Homann et al. 2000). Roughly
40-75% of alcohol consumed in an evening of drinking is absorbed in the stomach, with
some processed there to produce high levels of acetaldehyde in gastric juice (Lieber
2005; Salaspuro 2009). Microflora in the large intestine process residual alcohol and
alcohol diffused from the bloodstream to form acetaldehyde, but lack ALDH to oxidize it
to acetate. High levels of acetaldehyde in the saliva, gastric juice, and colonic contents
can be traced to the action of microbes and epithelial cells, increasing the risk of digestive
cancer (Salaspuro 2003).
Known Hazards
The presence of acetaldehyde in the beverage, especially when consumed at
chronically high doses, may contribute to the risk of human cancer in a variety of ways. It
may encourage the growth of bacteria in the gastrointestinal tract which are tolerant of
high acetaldehyde levels (Hooper, Wilson, and Crean 2009) and in turn produce more
acetaldehyde themselves (Salaspuro 2003). It may contribute to cancer directly by
generation of DNA adducts and DNA-protein crosslinks (Lorenti Garcia et al. 2009).
Acetaldehyde also decreases cell differentiation with chronic exposure, decreasing cell
adhesion to common extracellular matrix collagens and increasing proliferation (Koivisto
and Salaspuro 1998).
Dose Response
Dose-response information about acetaldehyde is limited by its chemical and
physical properties. It is volatile, evaporating at 20 °C. It contains an electrophilic
carbonyl carbon (Lorenti Garcia et al. 2009), making it highly reactive with biological
macromolecules including DNA, proteins, and phospholipids. It is constantly formed and
broken down in the presence of ethanol intake. Most ethanol processing takes place in the
liver, with significant processing along the alimentary canal as well. Though
concentrations of acetaldehyde in the blood are usually low, concentrations in the
digestive tract are increased by the presence of bacteria with efficient ADH, but
insufficient ALDH to break down the acetaldehyde generated (Salaspuro 1996).
Variability in the types and processing efficiencies of the bacteria in the digestive tracts
of individuals, as well as genetic differences in the human alcohol consumers, make
establishing a dose of acetaldehyde per dose of alcohol in humans very difficult. The
chemical and physical properties of acetaldehyde, as well as variations in the ability to
process ethanol limit the dose-response information it is possible to obtain about
acetaldehyde from alcohol consumption in free-living humans.
Some dose response information has been acquired despite the daunting
methodological challenges. Blood concentrations of 30 μM have been noted in
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alcoholics, with higher concentrations of 750 and 2410 μM in alcoholics actively
drinking (Brecher, Hellman, and Basista 1997). Acetaldehyde concentrations of 100-200
μM have been seen in the mouths of humans consuming beverages with high ethanol
content (Homann et al. 2000). Mice with ALDH2 knockout subjected to ethanol gavage
had blood acetaldehyde levels up to 247 μM, with wild type mice experiencing levels of
14 μM at the same ethanol dose (Isse et al. 2005). Measurable doses of acetaldehyde tend
to vary among subjects and species, depending on the ethanol dose, genetic background
of the subject, enzymes induced, and presence or absence of chronic alcohol
consumption.
Acetaldehyde Adduct Formation: Proteins and Enzymes
Mechanisms of Formation
Acetaldehyde is a reactive molecule, which can form protein adducts directly or
indirectly. It may interact with lysine residues or terminal amines to produce an unstable
Schiff base, which may be reversed or may be reduced to form a more stable adduct
(Grazi et al. 1963; Mauch et al. 1986). More recent studies have found that alcoholinduced aberrant lipid peroxidation in the liver produces malondialdehyde, which can
react with acetaldehyde and protein to produce protein adducts that may induce
inflammation and fibrosis (Tuma et al. 2001). Hydrogen peroxide and acetaldehyde react
with an amino group on a protein to form an unstable adduct. Malondialdehyde reacts
with another amino group to form a Schiff base. The Schiff base may be further reduced,
allwoing more complex combinations of reactions to occur among proteins. Such
modified proteins stimulate antibody production against the carrier proteins, causing fan
immune response to already-stressed liver cells. The resulting proteins may form a stable
product capable of stimulating cytokine release, inflammation, and fibrosis in the livers
of alcohol-fed rats (Figure1-4) (Tuma et al. 2001).
Consequences for Enzyme Activity
Several enzymes have been shown to be affected by interaction with
acetaldehyde. For example, carbonic anhydrase II has 24 lysine residues, and has been
shown to form Schiff-base adducts with 9-19 acetaldehyde molecules per molecule CAII.
This interaction slows the reaction rate of the enzyme (Bootorabi et al. 2008), which
could potentially lead to reduced gastric acid formation, reduced alkalization of
pancreatic secretions, and other secretory difficulties involving acid-base balance.
Acetaldehyde also affects lipoprotein lipase and hepatic lipase, altering lipid processing
in favor of atherosclerosis by increasing triglyceride levels and serum cholesterol
(Frohlich 1996).
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Figure 1-4. Formation of Protein Adducts with Acetaldehyde
Proteins react with acetaldehyde and malondialdehyde to form inflammatory adducts as
shown above. CH3CHO is acetaldehyde. CHOCH2CHO is malondialdehyde. Schiff bases
(bottom of figure) can combine with other adducts to form complex protein products that
elicit inflammatory responses in the liver.
Source: Reprinted with permission. Tuma DJ, ML Kearley, GM Thiele, S Worrall, A
Haver, LW Klassen, and MF Sorrell. “Elucidation of Reaction Scheme Describing
Malondialdehyde-acetaldehyde-protein Adduct Formation.” Chemical Research in
Toxicology 14 (7) (July): 822–832. Copyright 2001 American Chemical Society.
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Consequences for Cell Signaling
Chronic alcohol consumption triggers upregulation of CYP2E1, a cytochrome
P450 found in the endoplasmic reticulum (ER) (Gonzalez 2005). CYP2E1 releases free
oxygen radicals, resulting in oxidative stress to cells. Oxidative stress leads to an
accumulation of protein in the endoplasmic reticulum of liver cells, myocardium, and
cells of the cerebral cortex in mice (Ji 2012), resulting in the unfolded protein response
and ER stress. The stress response reduces protein synthesis and increases the capacity to
fold and unload proteins, restoring homeostasis to the cell if the stress is acute. If stress is
prolonged or chronic, as in the alcoholic, signaling changes predispose cells to apoptosis
by activating caspases and promoting mitochondrial leakage.
Acetaldehyde plays a critical role in this response to chronic alcohol consumption.
Acetaldehyde-protein adducts can be found in every organ tested of rats fed a chronic diet
of 15% ethanol (Biewald, Nilius, and Langner 1998). In biopsies from patients with
alcoholic liver disease, acetaldehyde-protein adducts were found in the rough ER and
microsomes of hepatocytes (Paradis et al. 1996). ADH overexpression, increasing
acetaldehyde exposure in mice fed ethanol, resulted in increased cardiac hypertrophy and
ER stress (Li and Ren 2008). ALDH2 over-expression, which decreases acetaldehyde
exposure, decreased ER stress and cardiac hypertrophy (Li et al. 2009). Acetaldehyde
exposure increases ER stress and predisposes cells to apoptosis in many vital organs of
the body.
Acetaldehyde has been shown to bind to tubulin and actin in vitro (Tuma, Jennett,
and Sorrell 1987; Xu et al. 1989). This binding causes inhibition of tubulin assembly at
concentrations as low as 200 μM with prolonged exposure (Tuma, Jennett, and Sorrell
1987). This binding may contribute to cytoskeletal changes observed in cells exposed to
acetaldehyde (Xu et al. 1989).
Acetaldehyde also affects beta-catenin and E-cadherin at the adherens junction in
a time-dependent manner. The adherens junction, found just below the tight junction,
functions as a point of cell-cell contact and communication. Acetaldehyde causes
dissociation of protein tyrosine phosphatase (PTP-1B) from the adherens junction,
resulting in phosphorylation of beta-catenin and disruption of the adherens junction
(Atkinson and Rao 2001; Sheth et al. 2007). Tyrosine phosphorylation has been
previously shown to cause relocalization of beta catenin to the nucleus of the cell and to
promote its binding to TATA- binding protein (a basal transcription factor) (Piedra et al.
2001). This binding activates the Wnt signaling pathway for proliferation (Klaus and
Birchmeier 2008). Accumulation of beta-catenin outside the adherens junction has been
shown to be a negative prognostic indicator in many cancers (Kren et al. 2003; Polette et
al. 2007; Caldwell et al. 2008). Thus the acetaldehyde-induced disruption of adherens
junctions may play an important role in cancer promotion.
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Acetaldehyde Adduct Formation: DNA
Mechanisms of Formation
Acetaldehyde interacts directly with DNA to produce DNA-acetaldehyde adducts
with the potential to stop both DNA and RNA polymerases during transcription, resulting
in mutations from the actions of DNA repair enzymes (Stein et al. 2006). These G-to-A,
T, or C mutations can result in protein malfunction. In ALDH2 knockout mice, alcohol
consumption with acetaldehyde accumulation results in increased formation of
DNAadducts and mutation of immune cells (Matsuda et al. 2007; Kunugita et al. 2008).
In human alcoholics with slow-metabolizing ALDH2, DNA-acetaldehyde adducts are
found at much higher levels than in subjects with normal ALDH2 (Matsuda et al. 2006).
An example of the formation of a relatively innocuous adduct which may be repaired
properly is shown (Seitz and Stickel 2007) (Figure 1-5A). Multiple acetaldehyde
molecules can also interact with DNA to form malondialdehyde and crotonaldehyde
adducts, which are more complex and may result in more likely DNA damage
(Figure 1-5B).
The acetaldehyde- DNA adduct N2-propano-deoxiguanosine has been shown to
be able to form inter-strand crosslinks between complementary DNA molecules (Lorenti
Garcia et al. 2009) (Figure 1-5B, C). Chromatid exchanges and DNA-protein crosslinks
occur in cell culture in a dose-dependent manner as well (Lorenti Garcia et al. 2009).
These results confirm increased levels of DNA damage in ALDH2-deficient alcoholics,
whose increased levels of acetaldehyde exposure predispose them to higher risk of aerodigestive cancers (Matsuda et al. 2006).
Mutations and Repair
Mutations due to adducts are not the only problem associated with DNA and
acetaldehyde. Acetaldehyde is known to interact with xanthine oxidase, increasing
production of superoxide, which cleaves folate (S Shaw et al. 1989). There is conflicting
epidemiological data, but some studies suggest that alcoholics tend to be folate deficient
due to their diets, and excessive alcohol consumption depletes blood folate supplies
(Ulrich 2007; Lightfoot et al. 2008) even further. This deficiency and depletion impedes
DNA synthesis and repair mechanisms, increasing the risk of mutation in colorectal cells.
Folate deficiency has been associated with improper methylation of tumor suppressor
genes in studies of colorectal adenomas (van den Donk et al. 2007). Other studies
suggest that defects in methylenetetrahydrofolate reductase (decreasing the amount of
folate available) and ADH (increasing the concentration of acetaldehyde) can combine to
create increased cancer risk (Hirose et al. 2005).
Acetaldehyde has been shown to promote dysfunction and cancer in a variety of
organ systems. In the respiratory system, it promotes bronchospasm and wheezing in
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Figure 1-5. DNA Adduct Formation in the Presence of Acetaldehyde
A. Acetaldehyde Adduct Formation. B and C. Formation of Crosslinks.
Source: Reprinted with permission. Seitz HK, and F Stickel. “Molecular
Mechanisms of Alcohol-mediated Carcinogenesis.” Nature Reviews. Cancer 7
(8)(August): 599–612. Copyright 2007 Nature Publishing Group.
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Japanese deficient in ALDH2 (Shimoda et al. 1996). In the rat gastrointestinal system,
high acetaldehyde levels in the stomach, small intestine, and colon from chronic
intoxication cause hypertrophy of gastric mucosa and intestinal crypts (Pronko et al.
2002). It contributes to neuronal death and cognitive deficits in alcoholics (Haorah et al.
2008). Acetaldehyde promotes lipid peroxidation and oxidative stress in the liver,
resulting in collagen production (Lieber 2005). All of these effects of acetaldehyde are
due to its metabolism and its adduct-forming capacity with proteins, lipids, and DNA.
The gastrointestinal epithelium is exposed to acetaldehyde from mouth to rectum
in chronic alcoholics. This exposure results in an increased risk of cancers of the mouth,
pharynx, esophagus, stomach, colon, and rectum (Homann et al. 2000; Akhter et al. 2007;
Seitz and Meier 2007; Salaspuro 2009). The bacterial inhabitants of the mouth and colon
have been shown to contribute to higher acetaldehyde levels in these areas than in the
bloodstream of alcoholics (Salaspuro 1996; Homann et al. 2000). Higher levels of
exposure to acetaldehyde result in detrimental effects to these parts of the body.
The detrimental effects of acetaldehyde may be focused on the junctional
complexes of gastrointestinal epithelia. These large protein complexes serve as a gate for
paracellular passage of ions and large molecules as well as a fence to preserve apicalbasolateral polarity (Schneeberger and Lynch 2004). Acetaldehyde disrupts tight
junctions, resulting in penetration of colonic bacterial endotoxins to the bloodstream
(Rao, Seth, and Sheth 2004). Because the mechanism of tight junction disruption is
poorly understood, it deserves examination in more detail. .
Tight Junctions
Historical Data
Tight junctions were first viewed by light microscopy in 1895, assumed to be bars
sealing the space between epithelial cells (Bonnet 1895). With advances in electron
microscopy, tight junctions were seen as fusions of cell membranes, binding epithelial
cells together in a manner similar to the mortar between bricks in a brick wall by sealing
the paracellular space between them with interwoven strands of protein (Figure 1-6)
(Farquhar and Palade 1963; Tamura et al. 2008). The discovery that some epithelia have
high resistance to the passage of ions, while others are "leaky", led to the discovery of
zonula occludens 1 (ZO-1) (Stevenson et al. 1986), a structural protein, and occludin, the
first trans-membrane protein of the tight junction to be discovered (Furuse et al. 1993). A
focus on the tight junction as a regulator of epithelial permeability has resulted in the
discovery of over 40 proteins interacting in a highly flexible and dynamic protein
complex (González-Mariscal, Tapia, and Chamorro 2008). Tight junctions are far more
than mere sealing sites between cells; they are active sites of protein-protein interaction.
Epithelial tight junctions serve to regulate the passage of ions and molecules
between cells, and to mark the division between apical and basolateral surfaces of cells in
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Figure 1-6. Electron Micrograph of the Tight Junction
Anastamosing strands of tight junction proteins in mouse upper small intestine are seen
by freeze-fracture and electron microscopy. Bar is one micron.
Source: Reprinted with permission. Tamura A, Y Kitano, M Hata, T Katsuno, K
Moriwaki, H Sasaki, H Hayashi, et al. 2008. “Megaintestine in Claudin-15–Deficient
Mice.” Gastroenterology 134 (2) (February): 523–534.
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cellular differentiation (Matter et al. 2005). Passage of ions and molecules is regulated by
to the actin cytoskeleton, allowing for changes in cytoskeletal arrangements as
intercellular contacts change (Hartsock and Nelson 2008). Each of these protein families
is critical to the overall function of the tight junction.
The claudin family of transmembrane proteins, which can homo- or heterodimerize to form pores of varying selectivity (Colegio et al. 2002). Apical-basolateral
separation of populations of proteins is critical to the maintenance of polarity and
differentiation status of epithelial cells (Matter et al. 2005), and is maintained by tight
junctions. Expression of a truncated version of occludin inhibited the ability of MDCK
cells to maintain fluorescently-marked lipids in their normal location on the apical
surface of the cell (Balda et al. 1996). Thus, the disruption of intestinal epithelial tight
junctions has two undesirable consequences: unwanted substances such as endotoxins are
allowed into the body, and depolarization of cells may be promoted (Laurent-Puig, Blons,
and Cugnenc 1999; Rao, Seth, and Sheth 2004).
Protein Classes
Tight junctions are complex assemblies of transmembrane proteins (occludin,
claudins, tricellulin, junctional adhesion molecules) (Aijaz, Balda, and Matter 2006),
scaffolding proteins (zonula occludens family, including ZO-1) (Fanning et al. 1998), and
signaling proteins such as protein kinases (Andreeva et al. 2006) and protein
phosphatases (Seth et al. 2007). ZO-1 and other scaffolding proteins attach this
complexto the actin cytoskeleton, allowing for changes in cytoskeletal arrangements as
intercellular contacts change (Hartsock and Nelson 2008). Each of these protein families
is critical to the overall function of the tight junction (Figure 1-7).
The first proteins of the tight junction to be discovered were the zonula occludens
proteins, including ZO-1 as the first member. ZO-1 is a 225 KDa protein found in a
variety of epithelial cells, acting as a scaffolding protein to connect transmembrane
proteins to the actin cytoskeleton (Stevenson et al. 1986; Fanning et al. 1998). ZO-1 is
part of the membrane-associated guanylate kinase (MAGUK) family of proteins (Fanning
et al. 1998). The proteins of this family contain PDZ, SH3, and GK binding domains,
enabling them to bind and interact with a variety of other proteins. ZO-1 also has a long
carboxy-terminal tail to enable further interactions. ZO-1 interacts with claudins and
junctional adhesion molecules through its PDZ domains, with occludin through its GK
binding domain, and with actin through its carboxy-terminal tail. It also binds ZONAB, a
Y-box transcription factor released to the nucleus when the claudin-ZO-1 association is
disrupted (Pannequin et al. 2007). ZO-1 is a vital scaffolding protein providing multiple
binding sites for a host of tight junction proteins, as well as binding factors that
communicate with the nucleus to drive transcription of factors increasing cell
proliferation when cell-cell contacts through tight junctions are disrupted.
Occludin is a 65 KDa transmembrane protein with four transmembrane domains,
two extracellular loops, and intracellular N-terminal and C-terminal tails
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Figure 1-7. Tight Junction Basic Structure
Transmembrane proteins include occludin, claudins, and JAM-1. Scaffolding proteins
include the ZO-1 family. These proteins provide binding sites for the transmembrane
proteins and actin.
Source: Reprinted with permission. Niessen CM. 2007. “Tight Junctions/Adherens
Junctions: Basic Structure and Function.” Journal of Investigative Dermatology 127 (11)
(November 1): 2525–2532. Copyright 2007 Nature Publishing Group.
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(Furuse et al. 1993; Feldman, Mullin, and Ryan 2005). Multiple phosphorylation and
binding sites on the C-terminal tail allow for interactions with ZO-1, kinases and
phosphatases (Chen et al. 1997). As the first transmembrane protein of the tight junction
to be discovered, it is known to increase tight junction integrity when over-expressed and
to play an important role in tight junction regulation. However, its functional role in the
junction was complicated by a study in which occludin null mice were generated (Saitou
et al. 2000). Tight junctions in these mice appeared normal, but the mice showed growth
retardation, chronic inflammation, gastric hyperplasia, brain calcification, and
reproductive abnormalities. Occludin does not appear to be essential for tight junction
formation, but does seem to be important in a variety of instances for regulation of
absorptive and secretory functions (Saitou et al. 2000). It also seems important in
regulating epithelial differentiation and senescence in breast and colon cancers (Osanai et
al. 2007; Luque-García et al. 2010). Because tight junctions can develop and appear
structurally normal without occludin, but tissues lacking it show abnormalities, its role in
tight junction regulation and maintenance is still under active investigation.
The transmembrane protein family that seems critical for tight junction pore
formation is the claudins, a group of 24 proteins. Claudins bear no sequence homology to
occludin, despite having similar transmembrane domains, extracellular loops, and
regulatory and binding domains (Furuse et al. 1998). They are smaller than other tight
junction proteins, with a molecular weight ranging from 20-27 KDa (Van Itallie and
Anderson 2006). Claudins homo- or hetero-dimerize to form paracellular pores of
differing charge and size, allowing for paracellular passage of small ions (Van Itallie and
Anderson 2006). Appropriate pore formation has been shown to be critical in promoting
the normal barrier function of the intestinal epithelium, and pathologies of claudin
expression have been associated with gastrointestinal diseases such as colorectal cancer
(Huo et al. 2009; Kinugasa et al. 2010).
The interactions among these molecules keep the tight junctions intact (Shin,
Fogg, and Margolis 2006). For example, occludin attaches to the N-terminal half of the
scaffolding protein ZO-1 via its carboxy-terminal cytoplasmic domain (Furuse et al.
1994; Fanning et al. 1998). Several different protein kinases facilitate this interaction by
phosphorylating the C-terminal tail of occludin (Andreeva et al. 2001).
Dephosphorylation of tight junction proteins by protein phosphatases result in their
internalization (Nunbhakdi-Craig et al. 2002). The interactions of transmembrane
proteins, scaffolding proteins, kinases, and phosphatases are essential to the functions of
the tight junction.
Recently these interactions have been discovered to be even more complex than
previously imagined. The tight junction complex appears to be highly dynamic, with
occludin diffusing within cell membranes to areas of photobleaching in steady-state cells,
with recovery of fluorescence on the timescale of 5-6 minutes (Shen, Weber, and Turner
2008). Claudin-1, in contrast, does not recover fluorescence at all, suggesting
stabilization and lack of exchangeability. ZO-1 shows an intermediate ability to move
into a photobleached area, and that mostly from intracellular pools (Shen, Weber, and
Turner 2008). Actin exchanges rapidly, showing increased exchange time only in 3-day-
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old as opposed to 1-day-old and 10-day-old MDCK monolayers. New and fully mature
monolayers seem to show dynamic protein interactions with movement of different tight
junction molecules among unique cellular pools by different mechanisms.
Phosphorylation and Function of Occludin and Claudins
With such a dynamic system, modes of regulation are critical to understanding
how the tight junction adjusts to different environmental stimuli. It is well known that
tight junctions may be disrupted in vitro by a variety of stimuli including phorbol esters,
calcium depletion, oxidative stress, and hydrogen peroxide. Studies have indicated
changes in the phosphorylation states of tight junction proteins, and their association with
each other, as a result of these disrupting factors. Changes in phosphorylation of tight
junction proteins happen prior to endocytosis of tight junction proteins and often mirror
changes in TER (Farshori and Kachar 1999). For example, claudins form chargeselective pores allowing for paracellular permeability that results in measurable changes
in transepithelial resistance (Van Itallie et al. 2006). Phosphorylation of claudins 1 and 4
by PKCs has been shown to promote tight junction formation and barrier function, as
does inhibition of PP2A (González-Mariscal, Garay, and Quirós 2010). Other tight
junction proteins also show significant patterns of phosphorylation and
dephosphorylation during tight junction formation and disassembly.
Serine, threonine, and tyrosine phosphorylation of occludin have been shown to
be important for tight junction assembly; a low-molecular weight, dephoshorylated form
of occludin does not go to the cell surface for tight junction assembly (Sakakibara et al.
1997; Wong 1997; Farshori and Kachar 1999). Phosphorylation of occludin by PKCζ on
threonines 403, 404, 424, and 438 of the C-terminal tail promotes tight junction assembly
(Jain et al. 2011). PKCη has also been shown to phosphorylate threonines 403 and 404
(Suzuki et al. 2009). Tyrosine phosphorylation via c-Src, in contrast to threonine
phosphorylation, is present only in occludin from disrupted tight junctions, as in cells
exposed to hydrogen peroxide (Basuroy et al. 2010). The interplay of these kinases and
others in phosphorylating different occludin residues is important for the assembly,
function, and disassembly of tight junctions (Andreeva et al. 2006).
Dephosphorylation by protein phosphatases has been shown to be important as
well. For example, acetaldehyde disrupts tight junctions by activating the
dephosphorylation of tight junction proteins by PP2A and PP1 (Seth et al. 2007). PP2A
and PP1 bind to the cytoplasmic C-terminal tail of occludin in the presence of
acetaldehyde, dephosphorylating it and causing its translocation from the tight junction to
the cytoplasm (Seth et al. 2007). This process is part of the destabilization of the tight
junction and loss of cell-cell contact, which can lead to aberrant cell growth (Polette et al.
2007). Phosphorylation and dephosphorylation of tight junction proteins allow for
assembly and disassembly of tight junctions.
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Figure 1-8. Adherens Junction Proteins
Adherens junctions are important for cell-cell adhesion and signaling. They contain
cadherins, catenins, kinases, and phosphatases. For the sake of simplicity only the
structural proteins are shown here. Cadherins are calcium-dependent transmembrane
proteins bound to members of the catenin family, which serve as a scaffold to link the
adherens junction to the cytoskeleton.
Source: Reprinted with permission. Niessen CM. “Tight Junctions/Adherens Junctions:
Basic Structure and Function.” Journal of Investigative Dermatology 127 (11)
(November 1): 2525–2532. Copyright 2007 Nature Publishing Group.
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Adherens Junctions
The adherens junction, located just below the tight junction, is critical for cell-cell
contact and communication (Figure 1-8). It forms and maintains contact between cells so
that the tight junction can assemble (Hartsock and Nelson 2008). Two primary proteins,
beta catenin, a scaffolding protein, and E-cadherin, a calcium-dependent transmembrane
protein, interact with the actin cytoskeleton and various kinases and phosphatases in a
manner similar to occludin and ZO-1 in tight junctions (Niessen 2007). The adherens
junction contributes stability to the tight junction, and factors disrupting one will often
disrupt the other.
Beta catenin localization has been a subject of active investigation for many
years, as nuclear localization of beta catenin causes activation of the usually-embryonic
Wnt signaling pathway, causing proliferation and stem-cell-like characteristics in cancer
cells (Fodde and Brabletz 2007). Dissociation of beta catenin from the adherens junction
and accumulation in the cytoplasm and nucleus is associated with increased disease
severity and metastasis in colorectal adenocarcinomas (Herter et al. 1999). Beta catenin
is also known to accumulate in the cytoplasm of cultured cells with reduced expression at
the cell membrane during cell migration assays (Polette et al. 2007). Once in the nucleus,
beta catenin binds to transcriptional activators LEF1 and TCF to activate expression of
genes for growth factors, cell proliferation markers, and components of the Wnt signaling
pathway, creating a feed-forward loop that encourages dedifferentiation and proliferation
(Klaus and Birchmeier 2008). The disruption of adherens junctions by a variety of factors
may dislodge beta catenin from its membrane-bound complex, enabling it to change the
functions and expression levels of proteins within the cell.
PP2A
Structure and Function
PP2A is a ubiquitous protein serine/threonine phosphatase, acting on a variety of
proteins in cell signaling pathways throughout the cell. In some cells, it comprises up to
1% of the total protein (Shi 2009). It negatively regulates the G2/M transition in mitosis
by inhibiting cyclin-dependent-kinase-activating kinase (Janssens and Goris 2001).
Inactivation of some of its regulatory subunits, or interaction with viral oncoproteins to
replace regulatory subunits, may result in cellular transformation by activating signaling
pathways involving, c-Myc, Wnt, and phosphoinositide-3-kinase (Sablina et al. 2010). It
also interacts with several proteins in the tight and adherens junctions to regulate cell-cell
adhesion and epithelial barrier properties (Seth et al. 2007; Nita-Lazar et al. 2010).
The activity and substrate specificity of PP2A are determined by it structure and
post-translational modifications to that structure. PP2A has three subunits: the A or
scaffolding subunit, the B or regulatory subunit, and the C or catalytic subunit (Arroyo
and Hahn 2005; US Cho and Xu 2007). The A and C subunits each have two isoforms,
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Figure 1-9. PP2A Subunits
The three subunits of PP2A are shown with their isoforms as named under different
naming systems. The A subunit is a scaffolding subunit to which the others bind. The C is
the catalytic subunit. Different B (B, B', B", B"') subunits determine localization and
substrate specificity. The ST is a viral protein that can replace the B subunit to change the
activity of PP2A.
Source: Reprinted with permission. Arroyo JD, and WC Hahn. 2005. “Involvement of
PP2A in Viral and Cellular Transformation.” Oncogene 24 (52): 7746–7755. Copyright
2005 Macmillan Publishers.
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and an AC dimer forms soon after protein translation (Janssens, Longin, and Goris 2008).
The B subunit has several isoforms including B55 (α, β, γ, δ), B56 (α, β, γ1, γ2, γ3, δ),
and PR72 (Janssens and Goris 2001), each of which confers different substrate specificity
on the catalytic subunit (Figure 1-9). Post-translational modification of the conserved
TPDYFL tail of the catalytic subunit by methylation via leucine carboxymethyltransferase 1 enhances binding of some B subunits, but not others(Stanevich et al.
2011). Phosphorylation of Tyrosine 307 inactivates the enzyme (Janssens and Goris
2001).
Inhibition Strategies
Cells regulate the amount and activity of PP2A so tightly that some techniques
normally used to explore protein function are difficult to achieve. Overexpression of the
catalytic subunit of PP2A is tightly regulated at the translational level (Janssens and
Goris 2001). Over-expressing the A subunit causes rat fibroblasts to become
multinucleated and disrupts the cell cycle (Wera et al. 1995). Knockdown of the A
(scaffolding) subunit or the catalytic subunit results in cell death in a variety of
mammalian cell types (Strack, Cribbs, and Gomez 2004). Knockout of the C-α subunit is
embryonic lethal in mice even when the C-β subtype is still present and active (Götz et al.
1998). The inability to knock down or overexpress subunits of PP2A without serious
impact on cell viability limits effective use of RNAi techniques normally used to examine
protein function.
To solve the problem of tight cellular regulation in exploring PP2A function,
pharmacological inhibitors and a recently-discovered peptide inhibitor were used. Natural
inhibitors exist, mostly from marine dinoflagellates, cyanobacteria, marine sponges, and
Streptomyces (Swingle, Ni, and Honkanen 2007). These compounds act by inhibiting
catalytic activity, enabling studies otherwise made difficult by tight cellular regulation of
PP2A expression.
Fostriecin is an antitumor phosphorus-containing compound isolated from
medium exposed to Streptomyces pulveraceus sp. fostreus (Stampwala et al., 1983).
Though its structure is similar to okadaic acid (another PP2A inhibitor), it is different in
several important respects, which make it a more specific inhibitor of the serine-threonine
kinase PP2A. The phosphate group on fostriecin binds the manganese ions in the active
site of PP2A directly. Fostriecin binds covalently to the cysteine-269 residue of PP2A
(Takeuchi et al. 2009). A nearby methyl group mimics the methyl group of the substrate
phosphothreonine. An unsaturated lactone may help to alkylate a cysteine on the active
site loop of PP2A (Buck, et al., 2003). These specific interactions enable fostriecin to be
a potent, specific inhibitor of PP2A (Swingle et al. 2009) (Figure 1-10).
Cell viability (as evaluated by growth inhibition using a cell count reagent) in
L1210 cells is unaffected with treatment of up to 10 μM biotinylated Fst for 72 hours.
This was a much greater concentration than that usually required (IC50 of 0.21 ug/ml)
(Leopold et al. 1984) for PP2A inhibition, so short-term viability of cells treated with
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Figure 1-10. Structure of Fostriecin
Fostriecin is a PP2A inhibitor.
Source: Reprinted with permission. Swingle S, L Amable, BG Lawhorn, SB Buck, CP
Burke, P Ratti, KL Fischer, DL Boger, and RE Honkanen. 2009. “Structure-Activity
Relationship Studies of Fostriecin, Cytostatin and Key Analogues, with PP1, PP2A, PP5,
and ({beta}12-{beta}13)-chimeras (PP1/PP2A and PP5/PP2A) Provide Further Insight
Into Inhibitory Actions of Fostriecin Family Inhibitors.” The Journal of Pharmacology
and Experimental Therapeutics 331 (1) (July 10): 45–53.
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fostriecin is not an issue.
Significance and Hypotheses
Acetaldehyde accumulates in the colonic lumen at high concentrations due to the
activity of alcohol dehydrogenase (ADH) expressed by luminal microflora. Chronic
ethanol consumption, with resulting production of acetaldehyde, elevates the risk for
colon cancer. A mounting body of evidence indicates that acetaldehyde disrupts adherens
junctions and tight junctions of the intestinal epithelium, which involves Thrdephosphorylation of occludin, a major tight junction protein. My studies show that
acetaldehyde disrupts adherens junctions and tight junctions leading to barrier
dysfunction by a mechanism that involves the activity of PP2A. Additionally, my data
indicate that acetaldehyde inhibits migration of Caco-2 cells on cluster plates. It also has
a negative effect on differentiation of Caco-2 cells into polarized epithelial cells when
grown in a 3-dimensional model on Matrigel. All these studies strongly support the
hypothesis that acetaldehyde destabilizes tight junctions and adherens junctions in the
intestinal epithelium by a PP2A-dependent mechanism.
The long-range goal of this project is to elucidate the mechanisms involved in
ethanol-induced increase in risk for colon cancer, and if such information can be utilized
to design therapeutics to prevent cancer promotion and tumor metastasis. As an initial
step toward this goal I investigated the role of PP2A in acetaldehyde-mediated disruption
of tight junctions and adherens junctions and evaluated the effect of acetaldehyde on the
morphology of cells during three-dimensional culture in Matrigel. .
Specific Aim 1: To determine the role of PP2A and Thr-dephosphorylation of
occludin in acetaldehyde-induced disruption of tight junctions and adherens junctions.
Sub-aims include the following:
A) Acetaldehyde disrupts tight junctions and adherens junctions by a PP2Adependent mechanism.
B) Acetaldehyde induces PP2A translocation by a tyrosine kinase-dependent
mechanism.
C) PP2A-mediated Thr-dephosphorylation of occludin is involved in acetaldehydeinduced disruption of tight junctions and adherens junctions.
Specific Aim 2: To determine that acetaldehyde alters migration and
differentiation by a PP2A-dependent mechanism. To reach this goal we will determine
that:
A) Acetaldehyde promotes cell migration by a mechanism that involves PP2A and
Thr-dephosphorylation of occludin.
B) Acetaldehyde alters morphology of cells grown in Matrigel in a dose-dependent
manner.
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CHAPTER 2.

METHODS AND MATERIALS

Cell Culture and Transfection
Cell Types Used
Caco-2 cells were purchased from the American Type Culture Collection
(Manassas, VA). Caco-2 cells were first isolated from a lung metastasis of a colon
adenocarcinoma in a 72-year-old man (Fogh 1975). After the cells were grown and
passaged in nude mice, the cells appeared to differentiate in vitro. They expressed brush
border enzymes and microvilli at the apical surface of the cell when fully differentiated,
at about day 20, in a similar manner to intestinal epithelia in vivo (Hidalgo, Raub, and
Borchardt 1989). These cells are used as a model system for the intestinal epithelium in
pharmaceutical as well as academic research applications (Hidalgo, Raub, and Borchardt
1989; Yamashita et al. 2000; Yamashita et al. 2002) . Cell growth and differentiation may
be carefully manipulated to mimic different stages of in vivo development of epithelia via
changes in medium and pH (Yamashita et al. 2000; Ranaldi et al. 2003; Moyes, Morris,
and Carr 2010). Because of the similarities between Caco-2 cell monolayers grown on
permeable polycarbonate membranes and intestinal epithelial cells in vivo, these
monolayers have become a prominent model for studying intestinal permeability and cell
signaling in the simplified in vitro environment.
Caco-2 cells were grown under standard culture conditions until seeding on
transwells for experiments. In summary, cells were grown in DMEM supplemented with
10% fetal bovine serum. Additional supplementation with 100 IU/ml penicillin, 100
μg/ml streptomycin, and 50 mg/ml gentamicin was also necessary at first due to
laboratory and building conditions outside our control. After a period of persistent
repeated contamination incidents, 1mg/10 ml Primocin, a proprietary non-cytotoxic broad
spectrum antimicrobial, antibiotic, and antimycoplasma solution became necessary for
work to continue. Experimental results showed that there was no loss of protein
expression or change in immunofluorescence staining due to this intervention.
Cells Grown in Transwells
Cells from passages 9-40 were used. Previous data indicated that cells in this
passage range express stable brush border enzymes, have predictable growth and
differentiation patterns, and produce reliable trans-epithelial resistance (Briske-Anderson,
Finley, and Newman 1997). Cells were grown on polycarbonate membranes for 7-11
days (6.5 mm Transwells), 11-14 days (12 mm Transwells) or 17-19 days (24 mm
Transwells) prior to incubation and experiments. These cells have been shown to
differentiate on permeable membranes within 2-3 weeks post-seeding, so these times of
growth post-seeding are well aligned with those in common use (Yamashita et al. 2000;
Yamashita et al. 2002; Behrens and Kissel 2003).
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Investigating the Role of PP2A
Inhibition of PP2A Activity with Fostriecin
Fostriecin is a potent antitumor antibiotic first isolated from a Streptomyces
pulveraceus culture in in 1983 (Tunac, Graham, and Dobson 1983; Stampwala et al.
1983). It was thought to act against murine leukemias by inhibiting DNA topoisomerase
II, but was later found to inhibit DNA, RNA, and protein production by inhibiting protein
phosphatase 2A (Walsh, Cheng, and Honkanen 1997). It inhibits PP2A by binding
covalently to the Cys-269 residue of the catalytic subunit (Takeuchi et al. 2009).
Fostriecin is advantageous for use because it is more selective for PP2A compared
to PP1 than other similar compounds (Swingle, Ni, and Honkanen 2007). For example,
okadaic acid, the most commonly used PP2A inhibitor, inhibits PP2A at an IC50 of 0.1 to
0.3 nanomolar. Okadaic acid inhibits PP1 at an IC50 of 15-50 nM. In contrast, fostriecin
inhibits PP2A at 1.5 to 5.5 nM, but PP1 at 45000-58000 nM. Fostriecin is more selective
than other available PP2A inhibitors, allowing a wider dose range for optimization and
reduced risk of inhibiting undesired phosphatases (Table 2-1).
Fostriecin is also able to enter cells grown under typical cell culture conditions
more readily than okadaic acid. Okadaic acid is hydrophobic, enabling it to penetrate the
cell membrane with ease. However, that very hydrophobicity can cause it to pool on top
of the cell culture media, isolated from the cells below. Fostriecin, a water soluble
compound incorporated into cells through the reduced folate transporter, can be delivered
to living cells in culture with more confidence of the actual dose accessible by the cells
than okadaic acid and other hydrophobic inhibitors (Swingle, Ni, and Honkanen 2007).
Cells were incubated with 50 nM fostriecin in Dulbecco's Modified Eagle's
Medium (DMEM) in apical and basal wells for 16.5 hours before each experiment. Cells
were washed with DMEM, and fostriecin was reapplied at the beginning of each
experiment to maintain PP2A inhibition.
Table 2-1. IC50 for Fostriecin and Okadaic Acid
Compound
okadaic acid
fostriecin

PP1
15-50
45,00058,000

PP2A
0.1-0.3
1.5-5.5

PP4
0.1
3.0

PP5
3.5
50,00070,000

PP7
>1000
not
determined

Source: Data used with permission. Swingle MS, L Ni, and RE Honkanen. 2007. “Smallmolecule Inhibitors of Ser/thr Protein Phosphatases: Specificity, Use and Common Forms
of Abuse.” Methods in Molecular Biology (Clifton, N.J.) 365: 23–38. .
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Knockdown of PP2A-Cα by SiRNA Transfection
Small interfering RNAs (siRNAs) are used to knock down expression of a target
gene for 3-5 days (Fewell and Schmitt 2006). These contain 19-22 base pairs to avoid the
cellular interferon response to long dsRNA viral sequences and subsequent global
downregulation of protein translation, which may lead to apoptosis (Paddison et al.
2002). These constructs knock down gene expression by mimicking an intermediate in an
endogenous gene expression regulatory pathway (Krol, Loedige, and Filipowicz 2010).
In the natural system, about 800 different small dsRNAs have been discovered in
humans (more in plants), which fine-tune the expression of a variety of proteins by
binding to mRNA using the miRNA induced silencing complex (miRISC). This binding
removes the poly-adenylyl cap of the mRNA and prepares it for degradation (Krol,
Loedige, and Filipowicz 2010). SiRNA mimics the last intermediate of this process,
which binds the miRISC complex to downregulate mRNA translation of the protein of
interest.
Caco-2 cells (approximately 125,000 cells/well) were seeded in six-well cluster
plates. After 24 hours of growth, cells were incubated in serum-free, antibiotic-free
DMEM for an hour. Cells were transfected using 100 μL Optimem, 12 μl Plus reagent,
and 7 μl oligofectamine with 150 μl DMEM and incubated for 6-8 hours. Medium
containing 10% serum was added, and cells were incubated at 37°C until the next day.
Cell monolayers were trypsinized and seeded onto Transwell inserts. TER was monitored
daily, and experiments were conducted on days 3 or 4, when TER stabilized at levels
indicating a confluent monolayer.
Peptide Inhibition of PP2A
TPDYFL is a universally conserved epitope at the C-terminal tail of the catalytic
subunit of PP2A (Xing et al. 2008). Methylation of the C-terminal leucine and
phosphorylation of tyrosine 306/307 help to determine regulatory B-subunit binding, and
thus activity, substrate specificity, and localization of PP2A (Bryant, Westphal, and
Wadzinski 1999; Deshmukh, Blunt, and Hofmann 2007; Longin et al. 2007). TPDYFL
peptide seems to interfere with binding of the B subunit with the AC dimer, thus
inhibiting activity and changing subcellular localization of PP2A (Deshmukh, Blunt, and
Hofmann 2007).
A delivery system for the inhibitory peptide had to be optimized for the Caco-2
cell line. The β-escin based transfection system used for cardiac myocytes (Deshmukh,
Blunt, and Hofmann 2007) caused Caco-2 cells to detach from the underlying substrate,
rendering them unusable for experiments. Instead we used the Chariot transfection
reagent system (Figure 2-1), a non-cytotoxic peptide-based system which allows
peptides or proteins to be transfected into cells without harsh reagents or electroporation
(Morris et al. 2001; Gros et al. 2006). The peptide of choice is incubated with the Chariot
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Figure 2-1. TPDYFL Transfection and Chariot Peptide
.
The chariot peptide reversibly binds the peptide to be transfected into the cell, allowing it
to pass through the cell membrane and to release for use on the other side.
Source: Reprinted with permission. Gros E, S Deshayes, MC Morris, G Aldrian-Herrada,
J Depollier, F Heitz, and G Divita. 2006. “A Non-covalent Peptide-based Strategy for
Protein and Peptide Nucleic Acid Transduction.” Biochimica Et Biophysica Acta 1758 (3)
(March): 384–393. Copyright 2006 Elsevier.

29

reagent for 30 minutes, forming a complex at concentrations dependent on the size of the
well in which the cells are contained. A simple titration is used to determine the optimal
amount of peptide and Chariot. An early trial involving Chariot and FITC-inulin
indicated nearly universal, low-level transfection, though transfecting fully confluent
monolayers is not recommended (Gros et al. 2006) . The Chariot reagent itself had no
effect on barrier function or cell viability. TPDYFL inhibitory peptide and scrambled
peptide were added at a concentration of 600 ng/transfection using the Chariot
transfection reagent system in fully confluent monolayers on transwells two hours before
experiments were conducted.
Acetaldehyde Treatment
Acetaldehyde was administered to cells as previously described (Rao 1998), in a
technique based on previous research in bovine bronchial epithelia (Sisson and Tuma
1994). In summary, cells were pre-incubated in PBS containing 1.2 mM CaCl2 and 1 mM
MgCl2, bovine serum albumin, and glucose for one hour. In cases such as peptide
transfection, in which the albumin might affect results by binding the peptide, DMEM
without antibiotics was used for pre-incubation. Transwells were placed in the center
wells of a cluster plate. Acetaldehyde solution was placed in the outer wells. and the plate
was quickly sealed. Control plates were sealed as well, and showed no signs of changes
in TER or flux due to oxygen depletion. The cells were exposed to vapor-phase
acetaldehyde at 200-600 μM concentration as described previously (Rao 1998) for time
periods ranging from 15 minutes to 5 hours, depending on the experiment.
Measurement of Barrier Function
Measurement of TER
Trans-epithelial electrical resistance (TER) was measured using a Millicell-ERS
Electrical Resistance System (Millipore, Bedford, MA). TER was demonstrated to
correlate to the permeability and morphology of the zonula occludens, now known as the
tight junctional protein complex, in the 1970s (Claude 1978). Total TER represents both
the transcellular and the paracellular resistance to the passage of small ions. Under
normal conditions in a confluent monlayer, TER depends on the packing of the cells,
space available between them, total surface area of the monolayer, and the probability
that pores (now known to be composed of claudin molecules) are open or closed (Claude
1978). "Normal" values determined from previous experience in the laboratory with
control cells from specific cell lines were used as a rough measure of monolayer integrity
before experiments began, and were used to monitor progress as well as determine the
effects of acetaldehyde. Calculations were completed using the following equation:
Resistancemeasured=(ΔVt/ΔIt)/A-Resistancemembrane and medium
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(Wills, Reuss, and Lewis 1996). In practice, the resistance of an empty well with medium
was subtracted from the resistance of experimental wells with confluent monolayers.
Percent change over the course of an experiment was used to determine efficacy of
treatment.
Trans-epithelial resistance is not always a reliable measure of paracellular
permeability. Because TER measures both transcellular and paracellular permeability,
cellular adaptations can mask the effects of stress on tight junctions. In addition, high
TER values may or may not correlate to other measures of paracellular permeability in
Caco-2 cells (Briske-Anderson, Finley, and Newman 1997). When occludin is overexpressed, TER increases while paracellular flux of small particles also increases,
perhaps through the influence of pore-forming claudins (Balda et al. 1996). Therefore,
other measures of paracellular permeability are necessary. .
Unidirectional FITC-inulin Flux
Flux of molecules including mannitol, polyethylene glycol, and FITC-inulin from
one side of a layer of cells to the other has been used to measure the integrity of epithelial
monolayers and evaluate their suitability for modeling transport of pharmaceuticals for
decades (Munck and Rasmussen 1977; Ghandehari et al. 1997). FITC-inulin has a
molecular weight of 3000-6000, and is not actively transported into or across cells. Thus
it is used as an indicator of tight junction integrity, as less than 0.5% of the inulin will
move across a healthy, differentiated, confluent monolayer (Ghandehari et al. 1997).
When the monolayer is compromised, gaps open between the cells through which large
molecules can pass, creating a leaky barrier (Rao 1998).
Mature cell monolayers on Transwells were incubated in different experiments
with 0.5 mg/ml FITC-inulin in the basal well. At the end of incubation with or without
acetaldehyde and/or inhibitors, 100 μl each of medium from the apical and basal wells
were sampled, and fluorescence was measured using a Flx-800 microplate fluorescence
reader (BioTEK instruments, Winooski, VT). Flux into the apical well was calculated as
the percentage of total basal well fluorescence/cm2 surface area.
Immunofluorescence Confocal Microscopy
After incubation and exposure to acetaldehyde, cell monolayers were fixed in 4%
paraformaldehyde in TBST (20 mM Tris, pH7.2, and 150 mM NaCl) for 15 minutes at
room temperature or in acetone methanol (1:1) on ice for 5 minutes. Monolayers were
permeabilized with 0.2% Triton-X 100 for 5 minutes. They were blocked in 4% milk in
TBST( 20 mM Tris. pH 7.2, 150 mM NaCl) for one hour. They were incubated with
primary antibodies for one hour and thirty minutes. They were washed and incubated
with secondary antibodies for one hour. Fluorescence was visualized using a Zeiss LSM
5 laser scanning confocal microscope, and images from 1 μm-thick x-y sections were
collected. Images were stacked using Image J software [NIH (National Institutes of
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Health), Bethesda, MD], and processed using Adobe Photoshop (Adobe Systems, San
Jose, CA).
Cell Viability Assay: Lactate Dehydrogenase Release
The Promega 96-well cytotoxicity assay was adapted to larger wells and used to
determine the degree of cell lysis in control and experimental cell monolayers. When cell
viability is compromised, cells release lactate dehydrogenase, which converts a
tetrazolium salt to a red formazan product. Changes in color are measured using a 96well plate reader at OD450. Color change is proportional to cell lysis, making the lactate
dehydrogenase assay a good measure of effects of cell treatments on cell viability
(Legrand et al. 1992).
Biochemical Analyses
Preparation of Cytoskeletal Fractions
Cell monolayers were washed twice with PBS, then incubated with lysis buffer
CS (Tris buffer containing 1.0% Triton-X100, 2 µg/ml leupeptin, 10 µg/ml aprotinin, 10
µg/ml bestatin, 10 µg/ml pepstatin-A, 1 mM vanadate and 1 mM PMSF) for 15 minutes
on ice. If fractions were to be used to measure PP2A activity, vanadate was not included
in the lysis buffer. Extracts were centrifuged at 15,600 x g for 4 minutes at 4 °C to
sediment the high-density actin cytoskeleton and associated proteins. The pellet was
resuspended in lysis buffer CS. Cytoskeletal fractions were mixed with Laemmli's sample
buffer and heated at 100 °C for 5 minutes.
Immunoprecipitation
After acetaldehyde treatment, the cells were washed with cold 20 mM Tris-HCl,
pH 7.4, and proteins were extracted using lysis buffer N (20 mM Tris, pH 7.4, containing
150 mM NaCl, 10 μg/ml leupeptin, 10 μg/ml pepstatin A, 10 μg/ml aprotinin, 10 μg/ml
bestatin, and 0.1 mM PMSF). Cell monolayers were extracted in 750 μl lysis buffer N,
then two monolayers per experimental condition were pooled for immunoprecipitation.
400 μg protein per condition was incubated with antibodies overnight. The next day,
protein complexes were precipitated with protein A/G sepharose beads. For activity
assays, beads were kept on ice until the assay (a few hours at most). For immunoblot
analysis, beads were heated at 100°C for 10 minutes with Laemmli's sample buffer to
release complexes. The sample buffer was frozen at -20°C until analysis could be done.
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Analysis of Phosphothreonine
Cells were lysed in lysis buffer D(0.3% SDS w/v, 10 mM Tris-HCl, pH 7.4,
containing 10 μg/ml leupeptin, 10 μg/ml pepstatin A, 10 μg/ml aprotinin, 10 μg/ml
bestatin, and 0.1 mM PMSF) at 100 °C. After repeated pipetting to homogenize samples,
samples were heated at 100 °C for 10 minutes. 400 μg protein per sample was incubated
with anti-phosphothreonine antibodies overnight, Protein complexes were
immunoprecipitated with protein A sepharose beads and samples processed as described
above.
PP2A Activity Assay
PP2A was assayed by a method adapted from (Fathi et al. 2002). Detergentinsoluble fractions or immunocomplexes were resuspended in PPase buffer (50 mM
HEPES, pH7.2, 60 mM NaCl, 60mM KCl, and protease inhibitors) to a volume of 20 μl.
These samples were incubated at 30°C for 10 minutes with 5μl (1 μg/μl) of KRpTIRR
phosphopeptide substrate. Free phosphate was assayed by adding 100 μl malachite green
reagent to each sample in a 96-well microtiter plate and incubating at room temperature
for 15 minutes . Absorbance was measured at 620 nm wavelength in a microplate reader
(SpectraMax 190, Molecular Devices, Sunnydale, CA). Assay was performed in the
presence or absence of 300 nM fostriecin and 100 nM okadaic acid. Units of PP2A
activity represent pmol free phosphate generated under assay conditions.
Immunoblot Analysis
Proteins were separated by SDS-polyacrylamide gel (4-12 % gradient)
electrophoresis and transferred to nitrocellulose PVDF membranes. Membranes were
blotted for different proteins using specific antibodies in combination with HRPconjugated anti-mouse IgG or HRP-conjugated anti-rabbit IgG antibodies. The blots were
developed using ECL chemiluminescence method (Amersham, Arlington Heights, IL).
The bands were quantitated by densitometric analysis using Image J software (NIH).
Animal Studies
Animals
These studies were conducted using an IACUC approved protocol. Adult male
mice (C57BL/6; 12 weeks old) were used for these studies. C57BL/6 mice are the
preferred strain for alcohol studies, as they consume alcohol willingly when not deprived
of food or water, and they have an active complement of alcohol-processing enzymes
(Middaugh et al. 1999; Westerlund et al. 2005).
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Acetaldehyde Treatment of Mouse Ileum
Segments of ileum were flushed and slit open longitudinally to prepare intestinal
sheets. These tissues were incubated in DMEM at 37°C with or without 50 nM fostriecin
for 15 minutes, followed by incubation with acetaldehyde (400 μM) for one hour as
described previously for transwell-grown cells. Tissues were cryofixed in OCT.
Preparation of Detergent-insoluble Fractions from Mouse Ileum
Mouse ileal mucosal scrapings were incubated for 15 min with lysis buffer CS.
Cell lysates were centrifuged at low speed (15,600 x g) for 4 min at 4C to sediment the
high-density actin cytoskeleton (detergent-insoluble fraction). Supernatant was used as
detergent-soluble fraction. The pellet was suspended in 200 µl of lysis buffer-CS and
sonicated to homogenize the actin cytoskeleton. Protein contents in different fractions
were measured by the BCA method (Pierce Biotechnology Inc, Rockford, IL). Tritoninsoluble and triton-soluble fractions were mixed with equal volume of Laemmli’s
sample buffer (2x concentrated) and heated at 100°C for 5 min.
Immunofluorescence Staining of Cryosections
10 μm cryosections were stained for occludin and ZO-1 by immunofluorescence
staining method as described above for transwell-grown cells.
Statistical Analyses
Comparison between two groups was made by Student's t-tests for grouped data.
Significance in all tests was set at 95% or greater confidence level. Sets with multiple
comparisons were checked by ANOVA as applicable using AnalystSoft Inc.,
StatPlus:mac LE, version 2009. See www.analystsoft.com.
Three-dimensional Cell Culture
Matrigel Cell Culture
Cells were cultured in Matrigel according to a protocol assembled from several
sources (Zhang et al. 2003; Debnath, Muthuswamy, and Brugge 2003; Xiang and
Muthuswamy 2006). Caco-2 cells were cultured under normal cell culture conditions to
confluency. Cells were trypsinized and pipetted gently to eliminate clumps. Matrigel was
thawed overnight on ice in a 4 °C refrigerator before use. It was preserved in aliquots at 20 °C to minimize freeze-thaw cycles. Each aliquot was thawed on ice before use and
preserved on ice during use. Matrigel solidifies in minutes at room temperature.

34

Plates were pre-coated with cold 100% matrigel before cells were deposited.
Plates were allowed to solidify in the incubator for 20 minutes before seeding. Avolume
of cell suspension in complete medium containing 2500- 20,000 cells with 100uL of
Matrigel, ice cold (for a 0.7 cm2 surface), was gently dripped onto the plate, aiming for
even coverage. Plates were placed in a 37 °C incubator immediately for gel to solidify.
When gel was solid (time varied by lot, about 20 minutes to one hour), cells were
overlaid with 0.2 ml DMEM with 10% FBS and primocin. New medium was added every
other day by manual aspiration of old medium, taking care not to aspirate the gel, and
gentle deposition of new medium.
Treatment of Matrigel Cultures with Acetaldehyde
Acetaldehyde treatment by vapor deposition every other day was modified from
Rao, 2008. In summary, cells were seeded in the central wells of a transwell or cluster
plate. At day 3 (to observe effects on differentiation) or day 7 (to observe effects on
growth), cells were treated with concentrations of acetaldehyde ranging from 0.003% to
0.2%, pipetted as a solution in PBS-BSA-glucose in the outer wells of the plate (24 ml
per plate). The plate was sealed and set in a dedicated 37°C incubator with 5% CO2 for
one hour. Then cells and plate were rinsed with PBS. Cells were fed new complete
medium and allowed to continue to grow. Cells were treated and photographed by phase
contrast microscopy every other day.
Fixation of Matrigel Cultures
Cells are stained in situ in the gel, so the process takes a longer time than in
monolayers grown on membranes, because the antibodies must diffuse through the
extracellular matrix. Nonspecific staining may also be a problem, if washing is not done
properly or staining is rushed. The protocols for 3D culture and processing were adapted
and optimized from previously published protocols in kidney and breast epithelial cell
models (Pollack, Runyan, and Mostov 1998; K Shaw, Wrobel, and Brugge 2004). During
all aspiration, manual techniques were used to avoid aspirating the gel.
Cultures were rinsed with PBS, pH 7.4, containing 1 mM CaCl2 and 0.5 mM
MgCl2 (PBS+) after experiments. Cells were fixed with 4% paraformaldehyde in PBS+ for
30 minutes. Cells were washed with PBS twice, then stored in PBS plus sodium azide,
0,05% until staining.
Immunofluorescence for Matrigel Cultures
Sections of membrane with gel and cells attached were carefully excised from
wells of a transwell plate and placed in a 24-well cluster plate. Cells were permeabilized
with 0.02% Tween-20 in PBS-IF for 30 minutes. Cells were blocked with 4% milk in
TBST for 2 hours. Then primary antibody was added at normal concentration for
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immunofluorescence in 4% milk in TBST. Plates were sealed with tape and placed in
cold room or 4 °C refrigerator overnight.
On the next day, cells were washed three times (10 minutes for each wash) with
1% milk. Secondary antibodies at manufacturer-recommended concentrations were added
and TO-PRO-3 in 4% milk. Resulting solutions were incubated 2 hours. Cells were
washed (10 min each) with IF-PBS.
Gels were mounted on pre-labeled Superfrost microscope slides. The gel was
gently removed from the membrane and placed in a drop of mounting fluid on the slide,
then a few more microliters of mounting solution were placed on top, then the coverslip.
Slides were sealed with fingernail polish, allowed to air dry, and stored at 4ºC in the dark.
Due to challenges in sealing the slides with thick and/or uneven gels, slides were
evaluated as soon as possible after preparation.
Cell Migration Assays
Background
When the intestinal epithelial barrier is breached by injury, a rapid process called
intestinal restitution ensures that exposure of the sterile internal environment to intestinal
contents is minimized. Then long-term healing processes can take place safely. Intestinal
restitution is of interest because of its function in wound healing after acute trauma and
its action in pathologies such as necrotizing enterocolitis, inflammatory bowel disease,
and Crohn's disease. In vitro and in vivo studies have found that a sequence of steps
occurs, including secretion of cytokines and growth factors, cell migration, and cell
differentiation. The restoration of barrier function is followed by a longer, slower process
of functional restoration via differentiation.
Cell migration is an essential part of the restitution process. Restoration of
intestinal epithelial barrier function after exposure to bile salts in porcine intestine
happens for large molecules within 30 minutes, with ion transport restored after 90
minutes to 2 hours (Argenzio, Henrikson, and Liacos 1988), a process too fast for cell
proliferation to play a role. Within 8 minutes, flattened cells were seen covering the
wounded surfaces, recovering their normal columnar morphology within 2 hours. Cell
movement is known to be dependent on actin skeletal reorganization and microtubule
formation, but the signals to and among cells engaging in migration are still under
investigation. A complex mixture of cytokines and growth factors is involved in the
process, and debate continues concerning the sequence and relative importance of these
factors, especially in the clinical setting.
The complex milieu of the large intestine also complicates matters. Cells are
exposed to a variety of commensal and pathogenic bacteria, immune cells and their
secretions, chemicals, and waste products as they migrate. Understanding which
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components of this milieu accelerate and which ones inhibit the healing process is
important for clinical applications in the treatment of necrotizing enterocolitis and
Crohn's disease.
In order to achieve an understanding of the normal and pathological processes of
wound healing, in vitro models of cell migration have been used to isolate and
characterize the migrating cells. These wound healing models usually involve growing
epithelial cells in a monolayer, then scratching or puncturing the monolayer to create a
hole. The cells can be observed during migration, and the cellular environment can be
altered or fully characterized much more easily than in a whole animal.
Wound healing in vitro proceeds according to certain predictable patterns,
dependent on cell type and culture conditions. In gastric epithelia, migrating cells
reorganize their actin cytoskeletons to form lamellipodia ("ruffles"), which can extend
into the wounded area. Cells extend these lamellipodia or pseudopods into the wound.
Then integrin molecules at the leading edge of the cell interact with extracellular matrix
molecules to form focal adhesions (Decaestecker et al. 2007). Matrix metalloproteinases
and serine proteases cleave proteins to allow the cells to continue moving forward.
Growing actin filaments push the membrane forward, as disassembly at the rear allows
for cell migration (Rafelski and Theriot 2004). Actin filaments are stabilized and
contracted by myosin and other contractile proteins of the cell. When the wound is
closed, the cells proliferate to normal cell density and reassume their normal shape and
function.
Cells of different types migrate in different ways and at different speeds. Immune
cells such as neutrophils may move individually in an amoeboid manner at speeds of 1520 microns per minute (Entschladen et al. 2005). Fibroblasts and tumor cells are
dependent on focal adhesion and move at 0.2-1 micron/min or 0.1-0.3 micron/min,
respectively (Entschladen et al. 2005). Colon and other epithelial cells migrate
collectively, moving slowly while maintaining intercellular junctions (Decaestecker et al.
2007). This collective movement contributed to the "purse-string" pattern of healing in
circular wounds (Tétreault et al. 2008). The different movement patterns and speeds of
different cell types contribute to complexity in migration studies.
Acetaldehyde Treatment
Migration was assayed using common methods, adapted from Liang, et al., 2007.
Cells were trypsinized from a confluent flask and seeded at uniform density in the center
two wells of six-well cluster plates. Upon reaching confluence (48-72 hours), the
monolayer was serum-starved overnight to reduce cell proliferation. Inhibitors of PP2A
were applied one hour before treatment. Cells were treated with acetaldehyde by vapor
deposition at varying concentrations for one or two hours, as described above. Wells
were washed thoroughly with PBS after treatment to remove acetaldehyde, then cell
monolayers were scratched with a razor blade or a 200 ul pipette tip. Holes were
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photographed at three hour intervals until 60-80% closure was achieved. Phase contrast
images were collected.
Analysis and Quantitation
Digital images were processed in Metamorph 7 or NIS-Elements (Nikon)
software. Measurement of 4-5 damaged areas per experimental condition in at least three
experiments was completed using Image J software. The average rate of migration was
calculated in Microsoft Excel by subtracting the area at the conclusion of the experiment
(after 6 or 12 hours) from the area at the beginning of the experiment, and calculating a
percent of area covered.
Sources of Materials
Reagents
Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum, and other cell
culture reagents were purchased from Invitrogen and Fisher Scientific. FITC-inulin,
leupeptin, aprotinin, bestatin, pepstatin A, phenylmethylsulfonyl fluoride, Triton-X-100,
Malachite green and protein-A sepharose were purchased from Sigma. Fostriecin and
okadaic acid were purchased from Calbiochem. PPase substrate phosphopeptide
(KRpTIRR) was purchased from Millipore (Upstate). All other chemicals were purchased
from Sigma or Fisher.
Antibodies
Mouse monoclonal PP2Aα and mouse monoclonal anti-e-cadherin were
purchased from BD Transduction (Franklin Lakes, NJ). Mouse monoclonal anti-occludin,
rabbit polyclonal anti-ZO-1, HRP-conjugated anti-occludin, rabbit polyclonal anti-pThr,
and anti-pSer antibodies were purchased from Zymed (San Francisco, CA). Alexa-fluor
488-conjugated anti-mouse IgG antibody was purchased from Invitrogen. Cy3conjugated anti-rabbit IgG antibodies were from Sigma. Rabbit anti-caspase 3 was
purchased from Chemicon. PP2A Aalpha antibody and goat anti-rat secondary HRP were
purchased from Santa Cruz.
SiRNA
Scrambled control RNA and siRNA specific to human PP2A-Cα (sequence
unavailable) were purchased from Dharmacon (Lafayette, CO).
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Peptide Inhibitor
Inhibitory peptide TPDYFL and scrambled peptide were custom-synthesized by
Genscript (Piscataway, NJ). Control scrambled peptide TPAYFA was also synthesized by
Genscript.
Matrigel
Matrigel was purchased from BD Biosciences ( Bedford, MA). All other reagents
were of analytical grade and were purchased either from Sigma or Fisher Scientific.
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CHAPTER 3.

RESULTS

Specific Aim 1: To Determine the Role of PP2A and Thr-dephosphorylation of
Occludin in Acetaldehyde-induced Disruption of Tight Junctions and Adherens
Junctions
Acetaldehyde Disrupts Tight Junctions and Adherens by a PP2A-dependent
Mechanism
Previous studies have shown that acetaldehyde in doses in the range used
throughout this thesis, 600 micromolar or less, are not cytotoxic to epithelial cells for the
time exposure (5 hours or less) used in our experiments (Grafström et al. 1994; Koivisto
and Salaspuro 1998; Rao 1998).
Cells were exposed to acetaldehyde at concentrations of 200-600 μM for 5 hours.
A lactate dehydrogenase assay for cytotoxicity was also performed for the same
conditions, with comparison to a positive control of cells incubated with 0.05% Triton X100 for 10 minutes.
TER declined and inulin flux increased in a time-dependent manner, indicating
that acetaldehyde disrupts tight junctions (Figure 3-1A, B). LDH assay confirmed that
levels of cell lysis were comparable to untreated controls and several-fold lower than
positive controls (Figure 3-2).
Acetaldehyde Disrupts Barrier Function in Caco-2 Cell Monolayers by a
Mechanism That Involves PP2A
Previous studies showed that acetaldehyde disrupts intestinal epithelial barrier
function, which was associated with dephosphorylation of occludin on Thr residues (Rao
2008; Sheth et al. 2007). PP2A was shown to regulate the Thr-phosphorylation of
occludin and tight junction integrity under calcium-switch conditions of tight junction
dis-assembly and reassembly (Seth et al. 2007). To determine whether the role of PP2A
was similar to that under calcium switch, I evaluated the effect of a PP2A inhibitor,
fostriecin, on acetaldehyde-induced barrier dysfunction in Caco-2 cell monolayers.
Caco-2 cell monolayers were pretreated with 50 nM fostriecin for 16 hours
followed by incubation with 200-400 μM acetaldehyde for 4 hrs. TER and inulin
permeability were measured at the end of incubation. TER was not affected by fostriecin,
nor did fostriecin ameliorate effects of acetaldehyde on TER (data not shown). However,
fostriecin did prevent acetaldehyde-induced increases in inulin flux (Figure 3-3). Recent
studies have indicated that the tight junction mechanisms responsible for the passage of
small ions and larger molecules are different.
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Figure 3-1. TER and FITC-inulin Flux in Acetaldehyde-treated Cells
TER was measured from Caco-2 cell monolayers treated with 200 μM acetaldehyde over
a time course of four hour or from control cells. B. Inulin flux was measured the same
sets of cells over the course of four hours.
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Figure 3-2. Effects of Fostriecin on Acetaldehyde-induced Tight Junction
Disruption
The lactate dehydrogenase assay indicates degree of cell lysis by measuring activity of
lactate dehydrogenase released into culture medium from cells. Activity was measured in
cells treated with acetaldehyde for five hours. Values for 0, 200, 400, and 600 μM were
not significantly different. Positive control was cells treated with TritonX-100 for 10
minutes.
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Figure 3-3. Effects of Fostriecin on Acetaldehyde-induced Tight Junction
Disruption
Cells with or without pre-treatment with fostriecin were sealed in cluster plates with or
without 200 μM acetaldehyde for up to four hours.* indicates statistically significant
difference in flux for treated cells versus control. # indicates statistically significant
difference in flux with fostriecin pretreatment from flux in acetaldehyde-treated cells
without fostriecin.
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For small ions, claudins form size-and-charge selective pores. For larger
molecules, temporary openings form between cells, perhaps regulated by occludin, in
ways that are not size or charge-dependent. For this reason, results for TER and FITCinulin flux are not always similar (Anderson and Van Itallie 2009). These results indicate
that acetaldehyde disrupts epithelial barrier function, as measured by passage of large
molecules, by a PP2A-dependent mechanism.
Acetaldehyde Disrupts Tight Junctions in Caco-2 Cell Monolayers by a Mechanism
That Involves PP2A
Acetaldehyde induces barrier dysfunction by disrupting the tight junctions
without affecting the cell viability. Results from TER and flux were contradictory, so we
evaluated the effect of pharmacological PP2A inhibition on the acetaldehyde-induced
redistribution of tight junction proteins.
Caco-2 cell monolayers were treated with fostriecin and acetaldehyde as
described above. Fixed cell monolayers were double labeled for occludin/ZO-1 by
immunofluorescence; images were collected by using a confocal microscope.
Occludin and ZO-1 were co-localized at the intercellular junctions in control cell
monolayers, indicating the presence of intact tight junctions (Figure 3-4). Acetaldehyde
treatment induced redistribution of occludin and ZO-1 from the intercellular junctions.
However, pretreatment of cells with fostriecin attenuated this effect of acetaldehyde.
PP2A inhibition protected tight junction protein localization.
Acetaldehyde Disrupts Adherens Junctions in Caco-2 Cell Monolayers by a PP2Adependent Mechanism
Acetaldehyde has also been shown to induce disruption of adherens junctions
(Samak, Aggarwal, and Rao 2011). This disruption causes internalization of occludin and
ZO-1. Adherens junction stability has been shown to influence tight junction stability
(Nita-Lazar et al. 2010). For these reasons I examined the effects of acetaldehyde and
PP2A inhibition on adherens junctions.
Caco-2 cell monolayers were treated with 50 nM fostriecin and 200 μM
acetaldehyde as described above. Fixed cell monolayers were double-labeled for Ecadherin and β-catenin by immunofluorescence; images were collected using a confocal
microscope.
Acetaldehyde treatment induced redistribution of E-cadherin and β-catenin from
the intercellular junctions. E-cadherin and β-catenin wew internalized by the cell in a
similar manner to occludin and ZO-1 at the tight junction. Fostriecin attenuated the
disruptive effect of acetaldehyde (Figure 3-5). These results demonstrate that
acetaldehyde disrupts adherens junctions by a PP2A-dependent mechanism.
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Figure 3-4. Confocal Images of Tight Junction Effects of Acetaldehyde and
Fostriecin
Caco-2 cells were pretreated with fostriecin for 16 hours, then treated with 200 μM
acetaldehyde for four hours. The cells were fixed with 4% paraformaldehyde and
immunostained for occludin and ZO-1.
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Figure 3-5. Effects of Acetaldehyde and Fostriecin on Adherens Junctions
Caco-2 cells were pretreated with fostriecin for 16 hours, then treated with 200 μM
acetaldehyde for four hours. The cells were fixed with 4% paraformaldehyde and
immunostained for beta-catenin and e-cadherin.
Acetaldehyde Disrupts Tight Junctions and Adherens Junctions in Mouse Ileum by
a PP2A-dependent Mechanism
Chronic alcohol consumption has been shown to promote colon cancer in rat and
mouse models by exposure to acetaldehyde in the gastrointestinal tract (Pronko et al.
2002). Since tight junction disruption may be part of the process of tumor promotion, we
decided to examine the effects of acetaldehyde on tight junctions in mouse ileum to
confirm our in vitro results. In vivo exposure to acetaldehyde is difficult to measure, so an
ex vivo experiment was performed to control the acetaldehyde administration.
We exposed mouse ileal segments to acetaldehyde at 300 μM for 60 minutes.
Tissues were cryofixed in OCT. They were sectioned and stained by immunofluorescence
for occludin and ZO-1 in a manner similar to that used for cell culture monolayers.
Tight junctions were disrupted by acetaldehyde, but not by fostriecin alone
(Figure 3-6). Treatment with fostriecin alleviated tight junction disruption, indicating
that PP2A is involved in acetaldehyde-induced disruption of tight junctions in mouse
tissues as well as in human cell culture.
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Figure 3-6. Effects of Acetaldehyde and Fostriecin on Mouse Ileum
Mouse ileum samples were treated with 300 μM acetaldehyde ex vivo in the presence or
absence of 50 nM fostriecin. Cryosections were stained for occludin (green) and ZO-1
(red).
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Knock Down of PP2A Attenuates Acetaldehyde-induced Barrier Dysfunction and
Tight Junction Disruption
Although fostriecin is a selective inhibitor of PP2A, it also inhibits PP4 and other
phosphatases at high concentrations. Therefore, we evaluated the effect of knockdown of
PP2A-Cα on acetaldehyde-induced barrier dysfunction. Caco-2 cells were transfected
with non-specific RNA or siRNA specific for PP2A-Cα. Transfected cells grown on
transwell inserts were exposed to acetaldehyde. Barrier function was analyzed by
measuring TER and inulin flux and tight junction integrity assessed by confocal
microscopy for occludin.
Immunoblot analysis showed that siRNA effectively reduced the level of PP2ACα in Caco-2 cells by roughly 25%. PP1 levels varied, with some experiments showing
no change and others showing an increase, perhaps as a cellular effort to compensate for
the knockdown of PP2A (Figure 3-7A). Acetaldehyde-induced increase in inulin
permeability in siRNA-transfected cell monolayers was significantly lower than that in
control-RNA-transfected cells (Figure 3-7B). Acetaldehyde-induced redistribution of
occludin from the junctions was attenuated in siRNA-transfected cells (Figure 3-7C).
These results confirm that PP2A plays a crucial role in acetaldehyde-induced disruption
of tight junctions.
Acetaldehyde-induces PP2A Translocation by a Tyrosine Kinase-dependent
Mechanism
Previous studies in our laboratory have shown that acetaldehyde -induced
disruption of tight junctions and adherens junctions increases tyrosine phosphorylation of
junctional proteins and reduced protein tyrosine phosphatase 1B(PTP-1B) activity
(Atkinson and Rao 2001; Sheth et al. 2007). Tyrosine phosphorylation and
carboxymethylation of PP2A on a terminal leucine are known to affect localization and
activity of PP2A by affecting the binding of B (regulatory) subunits. The following series
of experiments was undertaken to explore the effects of acetaldehyde on association of
PP2A and tight junction proteins, and to explore possible mediators of increased PP2A
association and activity.
Acetaldehyde Increases Association of PP2A with Occludin
It has been previously shown that PP2A associates with occludin when tight
junctions are disrupted by calcium depletion and in the presence of hydrogen peroxide
(Seth et al. 2007; Sheth et al. 2009). We investigated the association of PP2A with
occludin in the presence of acetaldehyde as a possible mechanism for acetaldehydemediated tight junction disruption. Cells were exposed to acetaldehyde for time periods
ranging from 15-60 minutes, based on initial trials of up to 2 hours, indicating that the
association peaked and faded within the first hour of treatment, before disruption was
apparent.
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Figure 3-7. SiRNA Knockdown of PP2A Attenuates Effects of Acetaldehyde
A. Western blot and immunostaining from total cell lysate indicate levels of PP2A, PP1,
and actin in cells treated with siRNA. B. Inulin flux in cells exposed to 400 μM or 600
μM acetaldehyde for 5 hours. * indicates significant difference in flux (p<0.02) vs.
control. # indicates significant effect of acetaldehyde in cells with PP2A siRNA (p<0.05)
vs. cells with scrambled siRNA. C. Cells were exposed to acetaldehyde for five hours at
two different acetaldehyde concentrations, then stained by immunofluorescence for
occludin and ZO-1.
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Immunoprecipitation of occludin from actin-cytoskeletal-associated fractions of
cell lysates followed short time course experiments. Half of each sample was used
immediately for PP2A activity assay, while the other half was used for immunoblot
analysis to determine occludin-PP2A association. PP2A activity was measured using the
substrate KRpTIRR and malachite green color change in the presence of free phosphate.
PP2A activity associated with occludin increased over time of acetaldehyde treatment
(Figure 3-8A). PP2A physical association with occludin peaked between 30 and 60
minutes after initiation of acetaldehyde exposure, corresponding roughly to activity data
(Figure 3-8B, C). These results indicate that PP2A association with occludin rises with
activity upon exposure of cultured human epithelial cells to acetaldehyde.
PP2A Translocation Inhibitor Attenuates Acetaldehyde-induced Barrier
Dysfunction and Tight Junction Disruption
Previous PP2A inhibition had shown attenuation of acetaldehyde-induced
disruption of barrier function, but siRNA knockdown of PP2A was unimpressive and the
pharmacological inhibitor could also inhibit PP4 and PP6. Another method of inhibition
was needed. TPDYFL is an inhibitory peptide previously used by another researcher in
our department in a study of cardiac myocytes (Deshmukh, Blunt, and Hofmann 2007).
Cells were treated with TPDYFL using the Chariot system to carry the peptide into the
cell. After two hours of pre-treatment, cells were treated with 200 μM acetaldehyde for
four hours. TER and flux were measured. Cells were fixed with paraformaldehyde and
stained for occludin and ZO-1. FITC-inulin flux data indicate that pre-treatment with
TPDYFL to inhibit PP2A alleviated the usual acetaldehyde-induced increase in flux
(Figure 3-9A). As with fostriecin treatment, short-term PP2A inhibition did not affect
TER (data not shown). Occludin-PP2A co-immunoprecipitation indicates that the usual
increase in PP2A association with acetaldehyde is attenuated by TPDYFL (Figure 3-9B).
Confocal images confirm that tight junctions appear to be more stable in the presence of
acetaldehyde in cells subject to TPDYFL PP2A inhibition (Figure 3-9C).
Tyrosine Kinase Activity Mediates Acetaldehyde-induced PP2A Translocation
Previous studies have shown that tyrosine phosphorylation on Y309 is important
for activation and localization of PP2A (Deshmukh, Blunt, and Hofmann 2007). Because
tyrosine phosphorylation has been previously shown to increase in tight junction proteins
in the presence of acetaldehyde, resulting in tight junction disruption, we examined the
effect of genistein, a known tyrosine kinase inhibitor, on the association between PP2A
and occludin.Cells were exposed to 200 μM acetaldehyde in the presence or absence of
100 μM genistein for one hour. In the presence of acetaldehyde, PP2A association with
occludin is increased within the first hour (Figure 3-10). With genistein treatment, the
association of PP2A and occludin did not increase with acetaldehyde treatment. A
representative blot is not available because these values were normalized to expression of
actin.
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Figure 3-8. Effects of Acetaldehyde on PP2A Activity and Association with
Occludin
A. In vitro PP2A activity assay from occludin immunoprecipitate in the presence of 200
μM acetaldehyde for exposure times up to one hour with or without fostriecin. *
represents significant change in PP2A activity (p<0.02) compared to controls. B. Coimmunoprecipitation of occludin and PP2A from same cell lysates as the activity assay
confirms increased association as well as activity. C. Densitometric analysis of several
co-immunoprecipitations confirms representative blot. * indicates significant difference
in PP2A-occludin association compared to controls (p<0.05).
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Figure 3-9. Effects of Peptide Inhibition on Acetaldehyde-induced Tight Junction
Disruption
A. FITC-inulin flux with TPDYFL pretreatment in the presence or absence of 200 μM
acetaldehyde for four hours. * indicates significant difference in inulin flux compared to
control. # indicates significant attenuation of acetaldehyde effect. B. Cells treated with
acetaldehyde were fixed in 4% paraformaldehyde and immunostained for occludin and
ZO-1.
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Figure 3-10. Genistein Effect on PP2A Association with Occludin
Densitometric analysis of three experiments with co-immunoprecipitation of PP2A and
occludin from cells pre-treated with 100 μM genistein, and treated with 200 μM
acetaldehyde. * indicates significant increase of association of PP2A with occludin in the
presence of acetaldehyde. # indicates significant decrease of association in the presence
of genistein compared to acetaldehyde-treated controls.
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Acetaldehyde Dephosphorylates Occludin on Threonine Residues by a PP2Adependent Mechanism
Threonine dephosphorylation of occludin, and involvement of PP2A, have been
demonstrated in previous studies in our laboratory examining the disassembly and
reassembly of tight junctions in the presence of altered calcium concentrations in cell
media (Seth et al. 2007). In this series of experiments, we explored the threonine
phosphorylation status of occludin in the presence of acetaldehyde treatment.
Cells were exposed to 200 μM acetaldehyde for time periods ranging from 15 to 60
minutes, after initial studies indicating that threonine dephosphorylation occurred within
the first hour. Occludin was dephosphorylated on threonine residues, with maximum
dephosphorylation occurring between thirty and sixty minutes after initiating
acetaldehyde treatment (Figure 3-11).
PP2A Translocation Inhibitor Blocks Acetaldehyde-induced Threonine
Dephosphorylation
Previous studies have shown that PP2A dephosphorylates occludin on threonine
residues as described above. We used TPDYFL, a specific peptide inhibitor, to examine
the effects of inhibiting PP2A translocation on threonine dephosphorylation. After two
hours of pretreatment with 500 ng peptide, the confluent monolayers were exposed to 200
μM acetaldehyde for time periods up to one hour. Results shown are for the 30-minute
time point, correlating with earlier data for fostriecin protection. Inhibition of PP2A using
a specific peptide inhibitor protects the phosphorylation of threonine residues of occludin
in the presence of acetaldehyde (Figure 3-12).
Tyrosine Kinase Activity Mediates Acetaldehyde-induced Occludin
Dephosphorylation
Previous studies of PP2A regulation have indicated that phosphorylation of Y307
is part of the activation of PP2A (Gentry et al. 2005). Since tyrosine phosphorylation of
tight junction and adherens junction proteins has been shown to be altered in the presence
of acetaldehyde (Atkinson and Rao 2001), we examined the effects of genistein (a known
tyrosine kinase inhibitor) on PP2A dephosphorylation of threonine in the presence of
acetaldehyde. Cells were pre-treated with 100μM genistein for one hour. They were then
exposed to 200 μM acetaldehyde for one hour. Cells were lysed and the actin
cytoskeleton-associated fraction was subjected to immunoprecipitation for threoninephosphorylated proteins. Immunoblot analysis for occludin and claudins followed.
In the presence of acetaldehyde, occludin threonine phosphorylation declines
(Figure 3-13A, B), but genistein protects occludin from dephosphorylation. Claudin-5,
another tight junction transmembrane protein, is also threonine-dephosphorylated in a
manner independent of tyrosine kinase inhibition (Figure 3-13A).
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Figure 3-11. Effects of Acetaldehyde and Fostriecin on Threonine Phosphorylation
of Occludin
A. Cells were pre-treated with fostriecin for 16 hours, then sealed into cluster plates in
the presence or absence of acetaldehyde for up to one hour. Immunoprecipitates of
threonine-phosphorylated proteins from actin-cytoskeleton-associated cell lysates were
immunoblotted for occludin. B. Densitometric analysis of three experiments is shown at
the 30 minute time point. * indicates significant difference in threonine phosphorylation
compared to control. # indicates difference in threonine phosphorylation with fostriecin
pretreatment.
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Figure 3-12. PP2A Inhibition with TPDYFL Restores Threonine Phosphorylation
of Occludin
Cells were pretreated with 500 ng TPDYFL for two hours before 30 miniutes of
treatment with acetaldehyde. Threonine-phosphorylated proteins were
immunoprecipitated from actin-cytoskeleton-associated cell lysates and immunoblotted
for occludin. * indicates significant difference (p<0.02) in threonine phosphorylation
with acetaldehyde treatment. # indicates significant difference (p<0.02) with pretreatment
with TPDYFL compared to acetaldehyde-treated cells without pretreatment.
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Figure 3-13. Effects of Tyrosine Kinase Inhibition with Genistein on Acetaldehyde
induced Threonine Dephosphorylation of Occludin
A. Cells pre-treated with 100 μM genistein or control cells were exposed to 200 μM
acetaldehyde for one hour. Immunoprecipitation of threonine-phosphorylated proteins
and immunoblot for occludin and claudin-5 followed. Loading controls ("input") from
total cell lysate for occludin and actin are included. B. Densitometry for threonine
phosphorylation of occludin in the presence or absence of 200 μM acetaldehyde and 100
μM genistein. * indicates significant difference (p<0.05) in threonine dephosphorylation
of occludin compared to control. # indicates significant difference (p<0.05) from
acetaldehyde-treated cells.
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Acetaldehyde-induced Activity of PP2A Does Not Depend on Changes in PP2A
Methylation Status
Studies of the regulation of PP2A activity have shown that terminal
carboxymethylation of L309 is important for substrate specificity and localization of
PP2A (Bryant, Westphal, and Wadzinski 1999; Xing et al. 2008). However, other studies
have shown that carboxymethylation is not necessary for B-subunit binding and PP2A
activity in all cases (Ikehara et al. 2007). Therefore we examined whether acetaldehyde
induced an increase in the methylation of PP2A as an explanation of its increased binding
and activity. Cells were treated with 200μM acetaldehyde for one hour. Total cell lysate
was immunoblotted for methylated PP2A C-α. Acetaldehyde treatment did not change
the amount of methylated PP2A as demonstrated by Western blot (Figure 3-14) at the
thirty minute or one hour time points, when PP2A was activated and translocated in
previous experiments. After repeatedly generating this result, we believe that methylation
of PP2A is not influenced by acetaldehyde.
Specific Aim 2: To Determine That Acetaldehyde Alters Migration and
Differentiation by a PP2A-dependent Mechanism
Acetaldehyde Promotes Cell Migration by a Mechanism That Involves PP2A and
Thr-dephosphorylation of Occludin
Two types of cell migration assays were attempted: scratch wounding and
transmigration. Transmigration did not work (data not shown) because the Caco-2 cells
did not pass through the 8-micron pores of a permeable filter upon acetaldehyde
stimulation. Caco-2 cells are used as a monolayer through which immune cells pass in
models of gastrointestinal immune function (Rescigno et al. 2001). They are also used as
a model for the invasion of Candida albicans by intra- and intercellular migration (Weide
and Ernst 1999). Other types of cells can migrate through membranes with a confluent
monolayer of Caco-2 cells, but the Caco-2 cells themselves do not move. The
transmigration model was attempted, but Caco-2 cells do not migrate across membranes
upon acetaldehyde stimulation.
Several types of scratch wounding were attempted. First, using a razor blade to
scratch away a large portion of the monolayer was used for experiments examining the
effect of hydrogen peroxide on FAK and Src signaling. In these experiments, I noted
difficulty with reproducibility because the blade often gouges the underlying plastic,
leaving small valleys the cells cannot cross in the migration process. I optimized the
technique using collagen coating of the plates prior to seeding, but the reproducibility
issues remained. I then attempted other scratch techniques from the literature including
using a fine metal-toothed comb (stippling, scraping, and stippling with rotation),
stippling or scraping with a gel-loading pipette tip, placing a tiny drop of acid on the
monolayer, and suction using a Pasteur pipette. Of all these techniques, the one yielding
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Figure 3-14. Methylation Status of PP2A in the Presence of Acetaldehyde
Cells were exposed to 200 μM acetaldehyde for 30 minutes or one hour. Total cell lysate
was immunoblotted for methylated PP2A C-α, with β-actin loading control.
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the most consistent results was stippling small holes with a gel-loading pipette tip.
Scraping a linear hole and watching the cells migrate to close it over time, as is done in
many other wound-healing models (Bindschadler and McGrath 2007), does not work
with Caco-2 cells due to their strong intercellular connections. A large or ragged hole, or
one ripped quickly and with force, increases the probability that the monolayer will
detach from the substratum, rendering it useless for cell migration purposes. Several
experiments using small round holes were conducted.
Acetaldehyde Inhibits Cell Migration in Caco-2 Cells at Low Concentrations
Acetaldehyde is known to disrupt tight junctions, and disrupted cell-cell junctions
have been previously demonstrated to promote cell migration. These experiments were
completed in an attempt to show that acetaldehyde promoted cell migration. Cells were
seeded in six-well cluster plates. After five hours of acetaldehyde treatment, confluent
cell monolayers were scratched with a pipette tip to form small holes (Figure 3-15A).
After six to twelve hours, scratches were examined for closure. Photomicrographs of
phase contrast images were saved as TIFs or JPEGs using Metamorph 8 or NIkon NISElements software. Images were compared from time zero to ending time points. Percent
closure was calculated by drawing outlines of the holes using Image J and calculating
changes in enclosed area with Microsoft Excel.
At concentrations several-fold lower than those used for typical Transwell
experiments, acetaldehyde did not promote cell migration. At the six hour time point
displayed, the lowest concentration of acetaldehyde inhibited migration (Figure 3-15B).
At normal concentrations used in Transwell experiments, cells detached (data not
shown). These results indicated that acetaldehyde may delay wound healing in
gastrointestinal epithelia.
Inhibition of Migration by Acetaldehyde Exposure is Not PP2A-dependent
Acetaldehyde exposure at high concentration has been previously shown in my
experiments to cause disruption of tight and adherens junctions in confluent cell
monolayers. Promotion of cell migration in the presence of this disruption was expected
based on previous studies in other contexts. Cells were exposed to acetaldehyde
concentrations including those typically used for acute exposure experiments in the
laboratory (100-300μM). Initial experiments in which these higher concentrations of
acetaldehyde tended to cause cell detachment led to experiments with a range of much
lower concentrations, as displayed below. After five hours of exposure to acetaldehyde in
sealed cluster plates, cell monolayers were scratched with a pipette tip and migration was
observed over the course of the next twelve hours.
All concentrations of acetaldehyde inhibited migration in a dose-dependent
manner, with inhibition not significantly rescued by fostriecin at any concentration
(Figure 3-16). Cells exposed to concentrations of acetaldehyde above 100 μM tended to
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Figure 3-15. Cell Migration Dose Response in the Presence of Acetaldehyde
A. Representative scratches and measurement technique are shown. Image J was used to
calculate each encircled area, with changes over time graphed in Microsoft Excel as
percent closure. B. Data from several dose-response experiments with treatment of cells
with acetaldehyde for five hours, followed by six hours of observation, are shown. * is
significantly different from control (p<0.2).
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Figure 3-16. Effects of Fostriecin at Range of Concentrations of Acetaldehyde
Cells in monolayers grown on cluster plates were treated with a range of concentrations
of acetaldehyde, with or without pretreatment with 50 nM fostriecin. * indicates wound
closure significantly different from control (p<0.02) after five hours acetaldehyde
treatment, wounding, and twelve hours wound closure.
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detach. Inhibition of wound healing by acetaldehyde at any concentration is probably not
PP2A-dependent.
Acetaldehyde Affects Growth and Differentiation of Caco-2 Cells by a PP2Adependent Mechanism
As discussed in the introductory chapter, alcohol consumption increases the risk
for colon cancer (Salaspuro 2009). Acetaldehyde formation seems to play a crucial role in
this effect of ethanol. Our studies described above show that acetaldehyde disrupts both
tight junctions and adherens junctions. Since the dissociation of tight junctions and
adherens junctions may result in morphological changes in cells, we investigated whether
acetaldehyde affected the epithelial differentiation of Caco-2 cells when grown in a 3dimensional model. Caco-2 cells were grown on Matrigel as described in the Methods
chapter. After 3 days of growth, cells were exposed to acetaldehyde (200 μM) for one
hour every day. The control group was treated similarly without acetaldehyde. On day
nine of growth, phase contrast images were collected. Cells were fixed with 4%
paraformaldehyde and immunostained for occludin and ZO-1.
Caco-2 cells on Matrigel grew to form a three-dimensional cyst-like structure,
consisting of a monolayer of polarized epithelial cells enclosing a central cavity. Phase
contrast images show that acetaldehyde at concentrations normally used for acute
exposure experiments attenuated the differentiation into cysts; rather, the cells appeared
dispersed without polarization. This was confirmed when the distribution of occludin and
ZO-1 was visualized by confocal microscopy. In control cells, occludin and ZO-1 were
co-localized at the apical end (facing the cavity) of the epithelial cells (Figure 3-17),
while such organization of occludin and ZO-1 was absent in acetaldehyde-treated cells.
These results indicate that acetaldehyde attenuates epithelial differentiation of Caco-2
cells.
Acetaldehyde-induced Differentiation Problems Are PP2A-dependent
Our studies described above show that acetaldehyde disrupts both tight junctions
and adherens junctions. Since the dissociation of junctions and adherens junctions may
result in morphological changes in cells, we investigated whether fostriecin influenced
the effect of acetaldehyde on morphological changes in differentiation, and whether a
lower dose of acetaldehyde would have an effect. Cells were grown in Matrigel following
previously-described protocols. Treatment with acetaldehyde started at day three, and
continued every other day until day twelve. Cells were pre-treated for one hour with 50
nM fostriecin.
Fostriecin attenuated the acetaldehyde-induced prevention of epithelial
differentiation. Fostriecin-treated cells with or without acetaldehyde showed organization
of cells into polarized epithelium in a cyst-like structure, similar to control cells
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Figure 3-17. Effects of Acetaldehyde at High Concentration on Growth in Matrigel
Cells exposed to 200 μM acetaldehyde for one hour, daily, are compared to control cells.
Phase contrast of cells at day 12 post-seeding is displayed with immunostaining for
occludin and ZO-1.
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(Figure 3-18A). Localization of occludin and ZO-1 were also affected (Figure 3-18B).
This study suggests that PP2A activity may play a role in acetaldehyde-induced
attenuation of epithelial differentiation
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Figure 3-18. Cells Exposed to Reduced Acetaldehyde Concentrations in the
Presence or Absence of Fostriecin
Cells were exposed to 25 μM acetaldehyde with or without pretreatment for one hour
with 50 nM fostriecin. A. Phase contrast images are shown at day 12. B. Cells were fixed
and stained for occludin and ZO-1.
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CHAPTER 4.

DISCUSSION

Acetaldehyde Disrupts Apical Junctional Complexes and Barrier Function in
Intestinal Epithelium by a PP2A-dependent Mechanism
Acetaldehyde, the most toxic product of ethanol metabolism, is involved in tissue
injury in several organ systems. Although acetaldehyde is well known to disrupt
intestinal epithelial tight junctions and increase paracellular permeability (Rao 1998;
Atkinson and Rao 2001; Rao 2008), the mechanism involved in this process of tight
junction disruption is poorly understood. Understanding the mechanism is important
because junctional-complex disruption contributes to liver disease in alcoholics, with
remediation by glutamine administration (Rao, Seth, and Sheth 2004), and is suspected to
contribute to the increased risk of aerodigestive cancers in alcoholics (Salaspuro 2009).
Our present studies show that concentrations of acetaldehyde used in our
laboratory disrupt tight junctions, but do not cause cell lysis in the time course used. LDH
assay indicated no more lactate dehydrogenase release in cells treated for five hours at
three of our highest concentrations than in controls. However, tight junctions and
adherens junctions were disrupted as indicated by FITC-inulin flux, TER, and the
redistribution of tight and adherens junction molecules as seen by immunostaining and
confocal microscopy. These results correlate with those obtained in earlier published
work from our laboratory and others (Rao 2008; Fisher, Swaan, and Eddington 2010)
Inhibiting the serine/threonine dephosphorylation of tight and adherens junction
proteins may help to protect the tight junctions. PP2A is known to interact with tight and
adherens junction proteins to dephosphorylate them (Seth et al. 2007; Nita-Lazar et al.
2010), so inhibition of PP2A was investigated in the context of acetaldehyde-induced
junctional complex disruption by three methods: pharmacological inhibition with
fostriecin, peptide inhibition with TPDYFL, and siRNA knockdown.
Fostriecin is a selective inhibitor of PP2A activity (Swingle, Ni, and Honkanen
2007). Our present study shows that pretreatment of Caco-2 cell monolayers with
fostriecin significantly lessens acetaldehyde-induced barrier dysfunction, as indicated by
TER and FITC-inulin flux. Attenuation of acetaldehyde-induced redistribution of
occludin, ZO-1, E-cadherin and β-catenin by fostriecin indicates that inhibiting PP2A
keeps apical junctional complexes intact in the presence of acetaldehyde.
The adherens junction is not a physical barrier to macromolecular transport across the
epithelium. However, it is known to indirectly regulate the integrity of tight junctions,
and therefore influence the barrier function. Previous studies indicated that redistribution
of e-cadherin and β-catenin plays a crucial role in acetaldehyde-induced barrier
dysfunction in Caco-2 cell monolayers (Sheth et al. 2007). The current study indicates
that the redistribution of e-cadherin and beta-catenin may be PP2A-dependent.
Because fostriecin inhibits PP4 and PP6 as well as PP2A, a non-cytotoxic,
specific inhibitor of PP2A was sought. The TPDYFL peptide, from a universally
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conserved motif at the c-terminal end of the catalytic subunit, met this need. After
determination and optimization of an appropriate delivery method, experiments to clarify
the role of PP2A and confirm the fostriecin data commenced. These studies were
conducted to seek insight into the mechanism of acetaldehyde-induced PP2A
translocation. Sub-cellular translocation of PP2A is known to be regulated by posttranslational modification at the C-terminal sequence TPDYFL (Ogris, Gibson, and
Pallas 1997; Bryant, Westphal, and Wadzinski 1999; Gentry et al. 2005). Previous
studies demonstrated that a synthetic peptide with this sequence altered PP2A
translocation and activity in cardiac myocytes (Deshmukh, Blunt, and Hofmann 2007).
Our study demonstrated that TPDYFL prevented acetaldehyde-induced tight junction
disruption and barrier dysfunction, as indicated by attenuation of FITC-inulin flux in the
presence of acetaldehyde and confirmed by immunofluorescence microscopy. These
results confirmed co-immunoprecipitation and PP2A activity data from the fostriecin
studies, indicating that PP2A translocation is an essential step in the mechanism of
acetaldehyde-induced tight junction disruption. Details of this mechanism remain to be
investigated.
Previous studies showed that overexpression of PP2A disrupted tight junction
integrity in MDCK cells (Nunbhakdi-Craig et al. 2003). Disruption of tight junctions by
calcium depletion involved increased association of PP2A with the tight junction protein
complex, and calcium-mediated reassembly of tight junctions was associated with
dissociation of PP2A from tight junctions in Caco-2 cell monolayers (Seth et al. 2007).
Inhibition of PP2A activity or knockdown of PP2A-Cα resulted in acceleration of
calcium-induced tight junction assembly (Seth et al. 2007). Furthermore, PP2A activity
was found to be involved in hydrogen peroxide-mediated disruption of tight junctions in
Caco-2 cell monolayers (Sheth et al. 2009). These previous studies led us to believe that
PP2A involvement in the acetaldehyde-induced disruption of tight junctions could be
productively investigated by PP2A knockdown with siRNA.
PP2A knockdown, however, is not without its disadvantages. Appropriate
expression of the A (scaffolding) subunit is critical for survival, and knocking it down
significantly, even in an inducible manner, causes cell death by apoptosis and necrosis
(Strack, Cribbs, and Gomez 2004). Suppression of the PP2A C subunit by more than
50% causes apoptosis and poor proliferation (Sablina et al. 2010). Suppression of the
B56 subunit recapitulates some, but not all, of the transforming features of the SV-40
small T antigen. PP2A suppression by siRNA must be used with caution, especially when
cell viability is important.
The role of PP2A in acetaldehyde-induced tight junction regulation was
confirmed by knockdown of PP2A using PP2A-Cα-specific siRNA. Though PP2A was
only knocked down by 20-25% in our experiments, knockdown of PP2A dampened the
effects of acetaldehyde on inulin permeability. It attenuated redistribution of occludin and
ZO-1 from the intercellular junctions. Our present study demonstrates by multiple
methods that PP2A is involved in acetaldehyde-induced disruption of tight junctions.
However, we do not know important details about PP2A in the context of the tight
junction. We do not know which B-regulatory subunits are involved in PP2A
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translocation to the tight junctions. Initial attempts to determine which B-regulatory
subunits of PP2A were involved in acetaldehyde-mediated tight junction disruption were
unsuccessful due to transfection problems with shRNA constructs. Trying again with
different constructs or a more tractable cell line may result in more detailed knowledge
about the specific PP2A B-regulatory subunits involved.
To establish the physiological relevance of the role of PP2A in tight junction
regulation in the presence of acetaldehyde, we determined the effect of acetaldehyde and
fostriecin on tight junction integrity in mouse intestine. Acetaldehyde induced
redistribution of occludin and ZO-1 from the intercellular junctions of epithelial
monolayers in mouse ileum incubated ex vivo with acetaldehyde, indicating that
acetaldehyde disrupts tight junctions in mouse intestinal epithelium. The presence of
occludin and ZO-1 at the tight junctions in mouse ileum treated with fostriecin
demonstrated that acetaldehyde-induced tight junction disruption in mouse intestinal
epithelium is also mediated by PP2A activity. Because lack of PP2A causes cell death,
and overexpression of PP2A also causes severe problems, genetic study of the role of
PP2A in acetaldehyde-induced disruption of intestinal epithelial junctions in vivo in mice
would probably be difficult. The inhibitors could offer a way around the problem, but
dosing would have to be carefully optimized to minimize morbidity.
Acetaldehyde Dephosphorylates Occludin on Thr Residues by a PP2A-dependent
Mechanism
A significant body of evidence indicates that tight junctions are regulated by
protein phosphorylation. Occludin is phosphorylated on serine and threonine residues,
and this phosphorylation is regulated by protein kinases such as c-Src, c-Yes, PKCη,
PKCζ and CK (Suzuki et al. 2009; Jain et al. 2011) and protein phosphatases such as
PTP1B, PP1 and PP2A (Seth et al. 2007; Sheth et al. 2007; Sheth et al. 2009).
Previous studies showed that PP2A binds to the C-terminal domain of occludin
(Seth et al. 2007; Sheth et al. 2009). Our co-immunoprecipitation studies demonstrated
that acetaldehyde increased the association of PP2A with occludin, indicating an
enhanced interaction of PP2A with the tight junction protein complex. PP2A activity
associated with occludin also increased on approximately the same time scale. Therefore,
it is likely that acetaldehyde enhances the direct interaction between occludin and PP2A,
enhancing PP2A's ability to dephosphorylate occludin and perhaps other proteins in the
tight junction complex. How this interaction is enhanced is currently unknown.
Our data show that acetaldehyde induces a rapid dephosphorylation of occludin
and other tight junction proteins on threonine residues. The occludin dephosphorylation
was effectively blocked by fostriecin, indicating that PP2A played a role in this effect of
acetaldehyde. The peptide TPDYFL also blocked dephosphorylation in the presence of
acetaldehyde, confirming the data from the fostriecin studies. PP2A translocation and
interaction with tight junction proteins is important for dysregulation in the presence of
acetaldehyde.
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The best-known means of PP2A activation and regulation are methylation of the
carboxy-terminal leucine of the C-subunit, and phosphorylation of Y307 (Ogris, Gibson,
and Pallas 1997). These interactions enable specific B-regulatory subunits to bind to the
A-C trimer, determining substrate specificity and subcellular localization. Previous
studies demonstrated that tyrosine kinase activity is involved in acetaldehyde-induced
tight junction disruption (Atkinson and Rao 2001). In the present study, the prevention of
occludin dephosphorylation on threonine by genistein indicates that tyrosine kinase
activity does play a role in acetaldehyde-induced PP2A translocation. According to
previous studies, phosphorylation of PP2A on Y307 negatively regulates its interaction
with the B-subunit (Ogris, Gibson, and Pallas 1997). Y307E mutation of PP2A Csubunit leads to loss of its interaction with the B-subunit and alters its substrate
specificity. Therefore, we speculate that tyrosine kinase activity and tyrosine
phosphorylation of PP2A may increase its affinity for occludin via binding of a Bregulatory subunit, causing dephosphorylation of occludin on threonine residues. Our
study also shows that acetaldehyde induces dephosphorylation of claudin-5 on threonine
residues. However, genistein failed to prevent this dephosphorylation, indicating that the
mechanism of claudin-5 dephosphorylation is distinct from that of occludin
dephosphorylation, and independent of the tyrosine phosphorylation of PP2A.
Prevention of acetaldehyde-induced tight junction disruption by TPDYFL
suggested that the acetaldehyde-induced PP2A translocation may be mediated by tyrosine
phosphorylation or carboxy-methylation. Methylation of L309 may be required for the
interaction of PP2A C-subunit with the B-subunit (Bryant, Westphal, and Wadzinski
1999). Our studies show that methylated PP2A is present in the untreated Caco-2 cells,
but acetaldehyde failed to alter the level of methyl-PP2A. This failure indicates that
methylation is not involved in the mechanism of acetaldehyde-induced PP2A
translocation, occludin dephosphorylation or tight junction disruption.
Further studies in this area are needed to determine how acetaldehyde activates
tyrosine kinase activity. Whether the actions of acetaldehyde are due to adduct formation
or activation of signaling pathways in the cell is unknown. Measurement of changes in
mass of occludin, claudins, PP2A, and other tight junction proteins could be used to
determine whether acetaldehyde causes direct adduct formation with these proteins.
Electrophoretic separation of proteins in a two-dimensional gel could be used to detect
changes in protein mass with acetaldehyde treatment. Mass spectrometry of isolated
proteins could be used to confirm changes found.
Acetaldehyde Inhibits Cell Migration by a Mechanism That Does Not Involve PP2A
Earlier studies have shown that chronic acetaldehyde treatment alters the
proliferation, adhesion, and differentiation properties of Caco-2 cells (Koivisto and
Salaspuro 1998). In the presence of low, non-cytotoxic levels of acetaldehyde (less than 1
mM) for up to 5 weeks, proliferation slowed, but continued to occur at half the pace of
untreated cells. Adhesion to collagens I and IV was altered, so that cells exposed to 1 mM
acetaldehyde could not be passaged due to low adhesion rates. Production of sucrase was
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altered, indicating problems with differentiation (Koivisto and Salaspuro 1998). These
studies suggested that acetaldehyde alters a variety of characteristics of Caco-2 cells,
which could be further investigated in our laboratory. With decreased differentiation and
altered cell-cell contact, we expected acetaldehyde to promote cell migration in a manner
that would be dependent on PP2A activity for the weakening of tight junctions. Previous
studies in migrating cells exposed to hydrogen peroxide had indicated accelerated
migration, so we expected faster migration with acetaldehyde exposure (Basuroy et al.
2010).
Two types of cell migration assays were attempted: scratch wounding and
transmigration. Transmigration did not work (data not shown) because the Caco-2 cells
did not pass through the 8-micron pores of a permeable filter upon acetaldehyde
stimulation. Caco-2 cells are used as a monolayer through which immune cells pass in
models of gastrointestinal immune function (Rescigno et al. 2001). They are also used as
a model for the invasion of Candida albicans by intra- and intercellular migration (Weide
and Ernst 1999). Other types of cells can migrate through membranes with a confluent
monolayer of Caco-2 cells, but the Caco-2 cells themselves do not move. The
transmigration model was attempted, but Caco-2 cells do not migrate across membranes
upon acetaldehyde stimulation, even when freshly-seeded, immature cells are used.
Scratch-wounding assays were attempted using a variety of methods. Scratchwounding assays involving a razor blade and scratching away a large cell surface resulted
in reproducibility issues due to scratching of the underlying plastic. A subsequent trial of
creating holes by various methods from the literature (small linear scratch, small circular
scratch, acid, suction) resulted in the selection of the small round hole cut with a
micropipette tip, a method previously used in several papers (Lotz, Rabinovitz, and
Mercurio 2000; Farooqui and Fenteany 2005). Due to cohesion of cells, the linear scratch
model most commonly in use resulted in ripping of the monolayer, with jagged wound
edges. Acid and suction resulted in large holes. The small, round hole technique was not
perfect, as compressed cells could block migration, but it was more reproducible than
other techniques.
Several experiments using small round holes were conducted. Repeated
experiments clearly demonstrated that acetaldehyde at very low (3 μM) and high doses
(100 μM) inhibited cell migration instead of promoting it, with mid-range doses
comparable to the migration of controls at time points less than twelve hours postwounding. Caco-2 cells may be acting as a "normal" epithelium under our current culture
conditions, in which case our migration assay models wound healing. Acetaldehyde
would inhibit wound healing in this case.
Immature monolayers of Caco-2 cells capable of migration seem to detach from
the underlying substrate rather easily. Acetaldehyde is known to alter the adhesion of
epithelial cells to underlying substrate in a dose-dependent manner (Koivisto and
Salaspuro 1998). This complicates the study of the effects of acetaldehyde on cell
migration. The mature monolayers used for other experiments can be exposed to higher
concentrations of acetaldehyde without detachment, but they do not migrate. For further
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studies, consideration of very low-concentration acetaldehyde for prolonged chronic use
might be appropriate.
The current results are relevant in the context of wound healing in alcoholics.
Alcoholics are well known for suffering a variety of surgical risks including delayed
wound healing and increased risk of infection (Tønnesen 1999). Acetaldehyde has been
shown in our experiments to cause PP2A-independent delays in wound healing, even in
an acute-exposure context. With the rise of binge drinking as an important phenomenon
among young people and a common cause of behavior-related trauma, understanding the
slowed wound healing caused by excessive alcohol consumption and subsequent
acetaldehyde exposure is important to optimize approaches to healing in inebriated
patients.
Acetaldehyde Alters Morphology of Cells Grown in Matrigel in a Dose-dependent
Manner
Growth of cells in Matrigel or collagen with added growth factors has become a
popular method to explore how cells grow and differentiate in a three-dimensional matrix
of extracellular proteins similar to those to which they would attach in vivo (Debnath and
Brugge 2005). It is used to model growth of cancer cells into tumors (Gudjonsson et al.
2003) and to explore tubulogenesis in renal tubule cells (Pollack, Runyan, and Mostov
1998). It has been used previously in Caco-2 cells to explore the role of integrins in
differentiation (Zhang et al. 2003), with differentiation in this context defined as
formation of a hollow spheroid of polarized cells, with the apical surfaces toward the
interior lumen. We expected that acetaldehyde exposure would disrupt this process by
disrupting the "fence" role of the tight junction in separating apical and basolateral
populations of membrane proteins.
Attempts to isolate cells after growth in Matrigel for further biochemical analysis
were unsuccessful despite use of techniques and buffers found to be productive in
multiple other cell lines. The end of the isolation procedure yielded no detectable protein.
All cells were lost. No Western blotting for changes in keratins or vimentin was possible.
In short, we know that PP2A influences the process of cell differentiation in the
presence of acetaldehyde in a manner we believe to be dose-dependent. However, the
difficulties encountered using the techniques required for these studies in the context of
our cell line, facilities, and the respiratory sensitization effect of acetaldehyde preclude
any conclusive statements or journal publications based on the data at this time.
Summary
In conclusion, this series of studies adds to the evidence that acetaldehyde
exposure affects the basic functions of intestinal epithelial cells in vitro and in vivo in a
dose-dependent manner. The negative effects on tight junction maintenance clearly
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involve threonine dephosphorylation of occludin and other tight junction proteins via
PP2A, as indicated by the rescue of tight junction localization of occludin in the presence
of acetaldehyde by pharmacological inhibition, peptide inhibition, and siRNA. Ex-vivo
studies of intact ileum confirm these findings. Migration studies show PP2A-independent
inhibition of migration in the presence of acetaldehyde. Differentiation studies remain
inconclusive until detailed biochemical analyses can be completed. PP2A affects a
variety of cell signaling pathways, and acetaldehyde reacts with a variety of cell
constituents. Their juxtaposition is a challenging study.
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